US20160184070A1 - Methods and systems for treatment of prolapse - Google Patents

Methods and systems for treatment of prolapse Download PDF

Info

Publication number
US20160184070A1
US20160184070A1 US15/065,362 US201615065362A US2016184070A1 US 20160184070 A1 US20160184070 A1 US 20160184070A1 US 201615065362 A US201615065362 A US 201615065362A US 2016184070 A1 US2016184070 A1 US 2016184070A1
Authority
US
United States
Prior art keywords
tissue
insertion tool
implant
region
arcus tendineus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/065,362
Inventor
Guillermo H. Davila
James E. Cox
Kimberly A. Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astora Womens Health LLC
Original Assignee
Astora Womens Health LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astora Womens Health LLC filed Critical Astora Womens Health LLC
Priority to US15/065,362 priority Critical patent/US20160184070A1/en
Publication of US20160184070A1 publication Critical patent/US20160184070A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B17/06109Big needles, either gripped by hand or connectable to a handle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0022Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed deep in the body opening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A61F2/0045Support slings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00805Treatment of female stress urinary incontinence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06004Means for attaching suture to needle
    • A61B2017/06009Means for attaching suture to needle having additional means for releasably clamping the suture to the needle, e.g. actuating rod slideable within the needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06004Means for attaching suture to needle
    • A61B2017/06042Means for attaching suture to needle located close to needle tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B2017/0608J-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • A61F2002/0072Delivery tools therefor

Definitions

  • Described herein are features of surgical articles, surgical methods, and surgical tools, for use in the field of pelvic surgery, e.g., to install support devices for use in treating vaginal prolapse.
  • pelvic prolapse develops when intra-abdominal pressure, muscle failure, a surgical procedure such as a hysterectomy, or other factors, allow or cause a tissue of a pelvic organ such as the vagina to become displaced.
  • specific types include vault prolapse (apical); cystocele (anterior); rectocele and enterocele (posterior); and combinations of these.
  • Nonsurgical treatments involve measures to improve the factors associated with prolapse, including treating chronic cough, obesity, and constipation.
  • Other nonsurgical treatments may include pelvic muscle exercises or supplementation with estrogen.
  • Methods of supporting vaginal tissue to treat vaginal prolapse can be differentiated in terms of the location of implanted materials or anatomical tissue used to support the vaginal tissue.
  • One current method of treating posterior vaginal tissue prolapse involves the use of an intravaginal slingplasty (“IVS”) tunneler device.
  • IVS intravaginal slingplasty
  • Methods of treating prolapse using an IVS tunneler involve supporting vaginal tissue by attaching a portion of a surgical implant to vaginal tissue and passing another portion of the implant through the iliococcygeus muscle below the white line, for support.
  • a different technique, known as sacrospinous ligament fixation involves supporting vaginal tissue by attachment to the sacrospinous ligaments.
  • the invention relates to transvaginal methods of treating posterior vaginal prolapse, and surgical devices.
  • Embodiments relate to methods, tools, and surgical systems useful for transvaginal placement of an implant (e.g., a synthetic mesh implant or an implant that contains a combination of synthetic and biologic materials) in a position to support posterior tissue of the vagina, wherein the implant passes bi-laterally through opposing tissue paths that each include passage at a region of the arcus tendineus, e.g., near the ischial spine.
  • an implant e.g., a synthetic mesh implant or an implant that contains a combination of synthetic and biologic materials
  • Some embodiments of methods may involve an external incision at a perirectal region, to place an extension portion of an implant, while alternate embodiments to not require and can avoid an external incision.
  • the implant can be introduced to the pelvic region transvaginally; transvaginally attached to tissue of the vaginal vault for support; and then distal ends of the implant can be passed bilaterally near a region of each arcus tendineus (e.g., near both of the patient's ischial spines), as described, using a transvaginal procedure.
  • tissue path through a region of the arcus tendineus can result in benefits including proper anatomical positioning of the supported vaginal tissue, and fixation of the implant in tissue near the arcus tendineus due to tissue ingrowth.
  • exemplary transvaginal methods can allow for the location of extension portions to be adjusted by movement of the extension portion extending through the tissue path, e.g., through a tissue path that surrounds the arcus tendineus.
  • an implant can be used to treat vaginal vault prolapse.
  • the support member can include a tissue support portion that can be attached to tissue of the vaginal vault and two end portions attached to the tissue support portion.
  • the implant can be used to place vaginal tissue in a therapeutic position for treatment of vaginal vault prolapse by attaching the tissue support portion to tissue of the vaginal vault, and attaching the end portions to separate locations for positioning or supporting the prolapsed tissue.
  • Exemplary implants, methods, tools, and systems provide anatomical support to treat vaginal prolapse (e.g., vaginal vault prolapse, enterocele, and rectocele) by using a supportive implant attached to vaginal tissue, that passes from posterior vaginal tissue to a location in a region of the arcus tendineus (“white line”), e.g., near the ischial spine.
  • the implant can pass from the point of attachment at the vaginal tissue, through a tissue path that includes passage through tissue at the immediately anterior edge of the ischial spine and at the level of the ischial spine near the connection of the ischial spine to the arcus tendineus, and above or below the arcus tendineus.
  • embodiments of the invention involve a tissue path that is defined to include a curved-rectangular-shaped area above and below the curved arcus tendineus.
  • the region includes a specific region having a height extending from 2 inches above to 2 inches below the arcus tendineus, and a length starting at the ischial spine and extending 3 centimeters to the anterior of the ischial spine.
  • the invention relates to a method of supporting posterior vaginal tissue.
  • the method includes: providing an implant comprising a tissue support portion and an extension portion extending from the tissue support portion, creating a vaginal incision, transvaginally contacting the support portion with posterior vaginal tissue, transvaginally producing a tissue path between the position of the tissue support portion and a region of the arcus tendineus, and transvaginally extending the extension portion through the tissue path.
  • the invention in another aspect, relates to a pelvic implant assembly that includes: an implant comprising supportive portions comprising a tissue support portion, and elongate extension portions extending from of the tissue support portion; and an insertion tool at a distal end of an extension portion, the insertion tool comprising a curved portion sized and shaped to be used in a transvaginal procedure to define a tissue path that exits the pelvic floor region in a region of the arcus tendineus, partially extends around an arcus tendineus, and re-enters the pelvic floor.
  • FIG. 1 illustrates anatomy relevant to the invention, including specific pelvic anatomy.
  • FIG. 2 illustrates anatomy relevant to the invention, including specific pelvic anatomy.
  • FIG. 3 illustrates anatomy relevant to the invention, including specific pelvic anatomy, and also exemplifies an implant according to the invention.
  • FIG. 4 illustrates an exemplary system of the invention including an exemplary tool and an exemplary implant with attached dilators.
  • FIG. 4A is an end view of an exemplary tool.
  • FIG. 4B is an end view of an exemplary tool with attached dilator of an implant.
  • FIG. 5 illustrates an exemplary implant according to the invention.
  • FIG. 6 illustrates an exemplary implant assembly according to the invention, including an implant and attached insertion tools.
  • FIG. 7 illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 7A illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 8 illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 9 illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 9A illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 10 illustrates an exemplary kit or system according to the invention, including a Desehampes Needle, an implant, and a tunneler device.
  • surgical implants can be used to treat conditions of vaginal prolapse.
  • various features of surgical implants, surgical tools, systems that include implant and tool, and surgical methods are useful for treating conditions of vaginal prolapse including vaginal vault prolapse, but will also be appreciated to be useful for treating other conditions of pelvic tissue prolapse.
  • the invention relates to methods, tools, and systems useful for attaching one portion of a surgical implant to pelvic tissue such as vaginal tissue and passing another portion of the implant through a tissue path that includes tissue in the region of the arcus tendineus or “white line,” preferably near the ischial spine.
  • the location of this tissue path passing through a region of the arcus tendineus or “white line” can result in improved anatomical correctness of the position of supported vaginal tissue.
  • the location in the region of the white line can provide a proper axis for supported vaginal tissue, higher than support provided by alternate methods of treating vaginal prolapse such as those that involve sacrospinous ligament fixation or use of the IVS tunneler, which alternate methods would typically produce a tissue path more directly through the buttocks.
  • a location in the region of the arcus tendineus, e.g., above the arcus tendineus does not cause vaginal tissue to be pulled down toward the pelvic floor as with attachment to the sacrospinous ligaments.
  • a better vaginal length can result compared to the use of an IVS tunneler, because the support is located closer to the ischial spine.
  • a tissue path can be one that wraps around the outside portion (relative to the region of the pelvic floor) of the arcus tendineus, meaning that an extension portion of an implant exits the pelvic region near the arcus tendineus (either above or below the arcus tendineus), continues along a path that wraps or bends around the white line, then re-enters the pelvic region on the other side of the white line; i.e., below or above the arcus tendineus, whichever is opposite of the direction of entry.
  • the tissue path can include a relatively sharp turning radius to place the extension portion near the arcus tendineus. By extending around the white line, the extension portion contacts tissue that surrounds the white line and can become ingrown into that tissue.
  • This ingrowth can provide fixation of the extension portion into the tissue.
  • the placement of the extension portion and implant can be adjusted by manipulating the extension portion from the pelvic region side, after passing the extension portion around the arcus tendineus.
  • the extension portion will include two portions within the pelvic region, and those two portions can be manipulated to adjust the position of one or more of the extension portion, a central portion of an implant, and tissue attached to a central portion of the implant.
  • FIG. 1 schematically illustrates a top view of anatomy of vagina and nearby tissue.
  • Vagina 2 and cervix 4 are schematically illustrated in relation to arcus tendineus or “white line” 6 , ischial spine 8 , and uterosacral ligaments 10 .
  • An exemplary region of a tissue path according to the invention, a region of the arcus tendineus, 6 is illustrated as an approximately-rectangular regions 12 (shown by dashed lines—one on each side of the pelvic region).
  • Each region 12 includes area above and below arcus tendineus, 6 , starting at ischial spine 8 and extending in an anterior direction along the length of the arcus tendineus.
  • region 12 is located to include or be adjacent to the obturator internus muscle (above the white line) and the iliococcygeus muscle (below the white line); a tissue path that passes through region 12 also passes through obturator internus muscle or iliococcygeous muscle.
  • a preferred example of a region of the arcus tendineus can be defined as a curved-rectangular-shaped area defined to include a region that extends 2 centimeters above and 2 centimeters below (e.g., 1 centimeter above and 1 centimeter below) the arcus tendineus and that has a length starting at the ischial spine and extending in an anterior direction along the arcus tendineus, e.g., a distance of up to about 3 centimeters anterior of the ischial spine (e.g., up to about 1 centimeter anterior to the ischial spine).
  • a particularly preferred tissue path can be very near or as close as possible to the ischial spine and either above or below the arcus tendineus, such as through tissue at the immediately anterior edge of the ischial spine and at the level of the ischial spine near the connection of the ischial spine to the arcus tendineus; dimensions can be 0.5 or 1 centimeter above or below the arcus tendineus, and 0.5 or 1 centimeter anterior to the ischial spine along the arcus tendineus.
  • FIG. 2 a top view of pelvic features, schematically illustrates sacrospinous ligament 11 , arcus tendineus 6 , ischial spine 8 , sacrum 16 , and exemplary tissue path 14 illustrated as circular line 14 passing around an outside of arcus tendineus 6 , i.e., wrapping around arcus tendineus 6 .
  • This wrapped configuration places an implant material near the arcus tendineus, e.g., in surrounding tissue such as surrounding muscle tissue, which allows for ingrowth of tissue into the implant material located at path 14 , and fixation of that implant material at that location.
  • FIG. 2 a top view of pelvic features, schematically illustrates sacrospinous ligament 11 , arcus tendineus 6 , ischial spine 8 , sacrum 16 , and exemplary tissue path 14 illustrated as circular line 14 passing around an outside of arcus tendineus 6 , i.e., wrapping around arcus tendineus 6 .
  • This wrapped configuration places an implant material near the arcus tendineus
  • Path 14 includes an arrow showing a direction of a needle (not shown) following path 14 , starting below arcus tendineus 6 , exiting the pelvic region by passing below the arcus tendineus and through the iliococcygeus muscle (levator ani) (not shown), passing around arcus tendineus 6 , and then passing back into the pelvic region by passing above the arcus tendineus 6 through the obturator internus muscle (not shown).
  • a needle not shown
  • FIG. 2 illustrates what can be referred to as a “bottom-up” technique for passage of an end portion or extension portion of implant material through a region of the arcus tendineus.
  • the bottom-up method inserts a distal end of an extension portion of an implant below the arcus tendineus and through the iliococcygeus muscle; the implant extension portion distal end is then passed around the back or outside of the anus tendineus to a location above the arcus tendineus, and then through the tissue above the arcus tendineus (i.e., through the obturator internus muscle) where the implant end then re-enters the region of the pelvic floor.
  • a tissue path as illustrated in FIG. 2 may be produced using a “top-down” method.
  • a top-down method inserts the implant extension portion distal end above the arcus tendineus through the obturator internus muscle, wraps the extension portion around the arcus tendineus, then the extension portion re-enters the region of the pelvic floor below the arcus tendineus by passing through the iliococcygeus muscle.
  • a top-down method may be a preferred method because top-down methods allow a needle tip to extend away from the bladder when passing through the obturator internus muscle.
  • the implant extension distal end after wrapping around the arcus tendineus and re-entering the pelvic floor region (i.e., through the iliococcygeus muscle), may be led through one of various tissue path options.
  • the end extension may re-enter the pelvic floor region and then extend to and terminate at a location internal to the pelvic region.
  • the distal end of the extension portion could be sutured, e.g., using a “stay suture,” to maintain placement within the pelvic floor. This method advantageously does not require an external incision for manipulating the extension portion.
  • Another variation of the method is to use a tissue path as mentioned, but that continues through the pelvic region and then to and through an external incision such as through the buttock and then through an external incision, wherein the extension portion can be adjusted and cut off to a desired length.
  • embodiments of the invention involve the use of a single mesh bridge (e.g., a uniform mesh strip) implant between tissue paths described herein, above the white line and optionally and preferably near the ischial spines, to repair vaginal vault prolapse.
  • a mesh strip implant may use a modified middle section with denser construction (e.g., use of a biologic material for a middle section, 22 ) to hold sutures better than standard mesh.
  • a vaginal vault repair results in an anatomically correct “pear” shape to the distal vagina, with the vaginal vault correctly positioned between the ischial spines.
  • FIG. 3 this figure illustrates a top view of the anatomy of FIG. 1 including a mesh support implant 20 installed according to an exemplary tissue path described herein.
  • Implant 20 includes central (tissue support) portion 22 sutured to the apex of vagina 2 by sutures 18 (designated as “x”s).
  • Implant 20 also includes two end portions, 24 and 26 , extending bilaterally from tissue support portion 22 . Each of end portions 24 and 26 is illustrated to pass from apex of vagina 2 , laterally toward arcus tendineus 6 .
  • Each end portion 24 and 26 passes above arcus tendineus 6 , near ischial spine 8 —i.e., through tissue at the immediately anterior edge of ischial spine 8 and at the level of the ischial spine near the connection of the ischial spine to the arcus tendineus—through the obturator internus muscle (not shown), around arcus tendineus 6 .
  • extension portions 24 and 26 are shown to continue through tissue below the arcus tendineus (i.e., through the iliococcygeus muscle, not shown) and back into the pelvic floor region.
  • sections 21 and 23 of end portions 24 and 26 are located internal to the pelvic floor region. During a surgical implantation procedure, these portions can be manipulated by grasping manually or with a surgical instrument such as a forceps, needle-passer, or pliers, to adjust the position of end portions 24 and 26 , as well as support portion 22 and overall implant 20 .
  • a surgical instrument such as a forceps, needle-passer, or pliers
  • the invention also relates to implants, tools, and kits, that may be used according to methods described herein, and that may also be useful for treating conditions other than vaginal prolapse, e.g., other types of pelvic tissue prolapse.
  • implants that may be useful according to methods described herein can include those types of implants known for use to treat vaginal prolapse, and similar implants.
  • Exemplary implants can be in the form of a biocompatible mesh material such as a mesh strip made of a single uniform length of mesh, or, alternately, can be a multi-portion implant that includes a support portion for attachment to pelvic (e.g., vaginal) tissue connected to end portions or extensions.
  • Embodiments include a length of mesh strip of generally uniform thickness and width, as well as implants having distinct or discernible sections of different sizes, materials, or mechanical properties.
  • Other exemplary embodiments include a tissue support portion of a biologic material and extension portions of synthetic mesh material.
  • Exemplary implants may be a mesh strip such as mesh strips and multi-component implants illustrated in the accompanying figures. As illustrated, exemplary implants may consist of a strip of uniform thickness and width, as well as implants that include portions of different sizes, shapes, and materials, for connecting to tissue and for supporting tissue.
  • a tissue support portion may be of a biologic material or a synthetic (e.g., mesh) material.
  • Attached to a tissue support portion can be one, two, or more, extensions (or “extension portions” or “end portions”) shaped and sized to extend from the point of attachment with the support portion of the implant to another location of the anatomy.
  • Each extension may be an elongate material that is biologic or synthetic, e.g., an elongate synthetic mesh attached directly to the support portion.
  • Implant products are available commercially for treating prolapse conditions, e.g., from American Medical Systems Inc., of Minnetonka Minnesota.
  • Examples of such products include: the line of PERIGEETM products for treatment of cystocele, from American Medical Systems, Inc.; the APOGEETM product for treating enterocele, rectocele, and vaginal vault prolapse, also available from American Medical Systems Inc.; as well as products for CAPS procedures (combined-prolapse-repair-with sling) for treating cystocele and stress urinary incontinence.
  • implants that can be used or modified for use according to the present description are described, e.g., in US application number 2004/0039453, “Pelvic Health Implants and Methods,” (describing implants useful for treating multiple pelvic disorders) having Ser. No. 10/423,662, and filed on Apr. 25, 2003; US application number 2005/0245787, “Method and Apparatus for Treating Pelvic Organ Prolapse,” having Ser. No. 10/834,943, and filed on. Apr. 30, 2004; U.S. patent application Ser. No. 11/347,063, filed Feb. 3, 2006, entitled “Pelvic Implants and Related Methods; U.S. patent application Ser. No. 11/398,368, filed Apr.
  • Exemplary implants can include a tissue support portion for placing in contact with tissue to be supported, and one or more “extension” portions (or “end portions”), the tissue support portion being useful to support pelvic tissue such as vaginal tissue (anterior, posterior, apical, etc).
  • the tissue support portion can be sized and shaped to contact the desired tissue when installed.
  • a tissue support portion that is located between two or more extension or end portions is sometimes referred to herein as a “central support portion.”
  • Dimensions of an implant or a portion of an implant can be as desired and useful for any particular installation procedure, treatment, or combination of treatments, and to support a specific tissue, type of tissue, or multiple tissues (e.g., bladder, vagina, urethra, etc.), Exemplary dimensions can be sufficient to allow the tissue support portion to contact tissue to be supported and to allow one or more extension portion to extend from the tissue support portion to a desired anatomical location, e.g., through a tissue path through a region of the arcus tendineus, as described.
  • a tissue support portion can be sized and shaped to an overall area for contacting tissue being supported, and can depend on the condition being treated, e.g., vault prolapse, enterocele, rectocele, or a combination of these.
  • the tissue support portion is of sufficient size and shape to at least partially surround or otherwise be in contact to support prolapsed tissue.
  • a tissue support portion can optionally be of a width that is greater than a width of an extension portion.
  • An increased width of a tissue support portion may take the form of one or two lateral extensions that extend the width of the tissue support portion in at least one direction, beyond the width of an extension portion.
  • the shape of the tissue support portion can also be varied, depending on the intended application and treated condition, and may be square, rounded, angled, rectangular, etc.
  • Exemplary widths of a tissue support portion measured laterally (i.e., perpendicular to lengths of extension portions), can be in the range from 1 to 8 centimeters, such as from 2 to 6 centimeters.
  • exemplary lengths of a tissue support portion can be up to 8 centimeters, such up to about 4 centimeters.
  • Extension portions are elongate pieces of material that extend from the tissue support portion and are integral with or connected to the tissue support portion. Extension portions are useful to attach to other anatomical features and thereby provide support for the tissue support portion and the supported tissue.
  • One or multiple (e.g., one, two, or four) extension portions can extend from the tissue support portion as elongate “ends,” “arms,” or “extensions,” that are used to attach to other anatomy. Extension portions extending from a tissue support portion in contact with posterior vaginal tissue, can be extended through a tissue path as described herein, passing through a region of the arcus tendineus such as above the arcus tendineus.
  • a width of an extension portion can be a width useful for implanting the implant and for providing desired strength and fixation properties during and after implantation and optional tensioning of the sling.
  • Typical widths of an extension portion can be in the range from 0.5 to 3 centimeters, e.g., from 0.8 to 2 centimeters, such as from 0.8 to 1.5 centimeters.
  • Extension portions can typically have a uniform or substantially uniform width along the length, normally not varying by more than about 25 percent of the average width along the length of the installed portion of the extension portion.
  • a length of an extension portion can be as desired to extend from a tissue support portion installed at a desired pelvic tissue location, through a tissue path of a desired length, e.g., from a tissue support portion installed at a vaginal tissue, to a region above the arcus tendineus, optionally back into the pelvic cavity, and optionally further passing through the buttock to an exterior incision external to the buttock.
  • FIGS. 4, 5, and 6 illustrate implants having supportive portions consisting of a tissue support portion and two elongate extension portions.
  • a suture may be attached to an implant, along a length of an extension portion, for use in adding tension or in positioning the implant or a portion (e.g., extension) of the implant.
  • an exemplary implant may include a removable sheath such as a flexible plastic, transparent elongate tube that can cover extension portions of an implant to allow a surgeon to apply tension or pressure on the sheath to indirectly apply pressure or tension to the extension portion, for placing or adjusting the location of the implant.
  • An implant can be installed according to the present description by use of standard surgical instruments, or by use of instruments that are designed or particularly useful for placing an extension portion through a tissue path as described, e.g., in a region of the arcus tendineus, such as above the arcus tendineus.
  • an insertion tool may include a portion for creating a tissue path, that portion being curved or straight, with exemplary embodiments including a curved portion of a sized and shaped (e.g., length and curvature) that will be useful to form a tissue path as described herein, in a region of the arcus tendineus and preferably wrapping around the arcus tendineus, to lead a distal end of an extension portion at least partially through a tissue path that wraps around the arcus tendineus.
  • a sized and shaped e.g., length and curvature
  • An exemplary length (measured as the circumferential arclength of the curved portion) of a curved portion can be from 3 to 5 centimeters, and an exemplary radius of curvature of a curved portion may be, e.g., in the range from 0.5 to 1.5 centimeters.
  • Exemplary geometric forms of a curved portion can be a form of a partial circle, such as a half circle.
  • the partial circle is arranged to be in a plane that does not include a line defined by a longitudinal axis of a shaft.
  • the curved portion can be located to define a partial circle having the shaft of the tool (and a longitudinal axis of the shaft) as a center of the circle.
  • the curved portion can then engage tissue and be rotated around the shaft and longitudinal axis by rotation of the handle about the longitudinal axis, to cause the curved portion to define a circular tissue path.
  • the partial circle can have a relatively uniform radius of curvature, such in the range from 0.5 to 1.5 centimeters (e.g., from 0.7 to 1.2 centimeters), extending over an arclength that traverses from 90 to 270 degrees, e.g., from 170 to 190 degrees, about 180 degrees.
  • This arclength when measured as the circumference of the partial circle, can be, e.g., from 3 to 5 centimeters.
  • An example of a useful insertion tool is a small curved needle attached at a distal end of an extension portion, which can be manipulated using a surgical instrument such as a forceps or pliers.
  • the small curved needle can consist of a single length of curved needle material, e.g., metal or plastic, attached at a distal end of the extension portion.
  • the needle may be considered to be a two-dimensional form, in that it the curvature of the needle can define a two-dimensional plane.
  • the small curved needle may be manipulated transvaginally and passed through tissue in a region of the arcus tendineus, preferably near the ischial spine.
  • the needle is curved to exit the pelvic region, wrap around the ischial spine, and then lead the extension portion back into the pelvic region to cause the extension portion to follow a tissue path that wraps around the arcus tendineus.
  • the needle may then be removed by cutting the extension portion and the position of the extension portion may be adjusted by manipulation of portions of the extension portions that are located within the region of the pelvic floor.
  • a tool useful for placing an end portion of an implant transvaginally is a small three-dimensional looped needle such as a Deschamps needle or a similar needle that can be introduced transvaginally and that can then be used to pass an end portion of an implant through a tissue path in a region of the arcus tendineus, e.g., at the level of the ischial spine.
  • the tool can be considered to include a shaft and curved end portion that exist in three dimensions, with the shaft defining a longitudinal axis and the curved end portion originating from that axis and extending in two additional directions.
  • an end portion of an implant may be attached to a tip of a curved distal portion of the tool and passed through tissue of a region of the arcus tendineus using the curved tip, transvaginally.
  • the curved distal end portion can be inserted transvaginally, and the handle can be rotated to rotate the curved distal end portion to define a circular tissue path.
  • the needle is curved to exit the pelvic region, wrap around the arcus tendineus, and then lead the extension portion back into the pelvic region to cause the extension portion to follow a tissue path that wraps around the arcus tendineus.
  • an additional surgical tool such as a tunneler (e.g., the IVS Tunneler device available commercially from Tyco) can be inserted through an external incision (e.g., in a perirectal region) into the pelvic region, attached to a distal end of the extension portion, and then removed to lead the extension portion of the implant from the pelvic region to an external location.
  • a tunneler e.g., the IVS Tunneler device available commercially from Tyco
  • An insertion tool or tools may engage a distal end of an extension portion of an implant by any useful engagement configuration.
  • the engagement may be a permanent attachment or removable engagement, as desired.
  • an insertion tool may be attached to the implant at a distal end of an extension portion.
  • the term. “attach,” when used with regard to an end portion attached to an insertion tool, will refer to engagement configurations that are not easily removable, such as in an a manner designed to be used during a surgical implantation method and that would normally be removed only by cutting the extension portion of the implant, as opposed to releasing (e.g., un-threading) the implant from the insertion tool.
  • attachment mechanisms include attachment by adhesive such as a pressure sensitive adhesive, a structural adhesive, a two-part reactive adhesive such as an epoxy adhesive, etc.; a tight knot using thread or suture material that would not be easily untied during a surgical installation procedure; a non-removable mechanical interaction between the insertion tool and the implant portion such as by permanently threading the implant portion through an eye, eyelet, slot, or hole in the tool so the end portion is not easily removed; a metal or plastic mechanical attachment such as a metal crimp at the end of the insertion tool; a polymeric attachment such as the use of a heat-shrinkable polymeric sheath; attachment by a molding manufacturing process such as by injection molding or insert molding a plastic dilator or plastic needle to a distal end of an extension portion; or any other mechanical or adhesive type of permanent or semi-permanent attaching mechanism.
  • adhesive such as a pressure sensitive adhesive, a structural adhesive, a two-part reactive adhesive such as an epoxy adhesive, etc.
  • examples of types of removable engagement mechanisms include use of a loose knot that is easily untied during a surgical implantation procedure; an threaded dilator that removably engages a threaded needle tip for easy engagement and dis-engagement by threading and un-threading; and threading a distal end of an extension portion through an aperture (e.g., eye or eyelet) of an insertion tool such as a needle or a curved distal portion of a tool.
  • an aperture e.g., eye or eyelet
  • an insertion tool e.g., dilator, needle, etc.
  • a distal end of an extension portion of an implant eliminates the need for a surgeon to make that connection, which reduces preparation of the implant before or during surgery.
  • the term “pre-attached” refers to an implant that includes an insertion tool attached to the implant as the implant is commercially supplied to a surgeon.
  • the pre-attached device can be manufactured for distribution and sale in a condition where only minimal preparation (if any at all) needs to be performed by the surgeon prior to surgical implantation.
  • Minimal preparation may include modification to size or shape of a portion of an implant (e.g., by trimming), or removing loose material or loose pieces, but does not include a step of creating a direct attachment between a portion of the implant and an insertion tool that will allow the portion of the implant to be placed or led through a tissue path.
  • embodiments of optional features of implants include an insertion tool that is attached e.g., pre-attached, or alternately is removably engaged, at a far (i.e., distal) end of an extension portion of an implant, the tool being a structure that facilitates installation of the extension portion and implant by being of a size, shape, rigidity, and overall design, to be capable of being used transvaginally to create a tissue path that passes through tissue in a region of the arcus tendineus, optionally and preferably wrapping around the arcus tendineus.
  • Examples of insertion tools that may be either attached or removably engaged to a distal end of an extension portion include: a tip (distal end) of an extension portion that includes an attached rigid tip or “dilator,” optionally designed to cooperate and removably engage an end of another insertion tool for use together to create a tissue path during installation of an implant; a distal end of an extension portion that is permanently attached to an insertion tool in the form of a curved distal needle portion and a shaft and proximal handle portion, or another tool that can be inserted transvaginally to manipulate an extension portion of an implant during installation; and a distal end of an extension portion that is permanently attached to an insertion tool such as a small needle that can be manipulated by a grasping tool such as a needle driver, a forceps, or a pliers, etc., to manipulate an extension portion of an implant during transvaginal installation.
  • a tip distal end of an extension portion that includes an attached rigid tip or “dilator,” optionally designed to cooperate
  • an implant may include a rigid (e.g., plastic), pushable dilator attached at a distal end of an extension portion, the dilator including a sharp tip at a first end and an opening at an opposing end, the opening designed and adapted to fit and removably engage an end of an insertion tool such as a needle.
  • the pushable dilator can be designed to fit the leading edge of an insertion tool such as a long needle having a handle and a distal portion with a tip adapted to fit and removably engage the pushable dilator.
  • the dilator can engage the end of the insertion tool and may be pushed or pulled by the insertion tool through tissue to either follow or produce a path in the tissue, such as by rotating the handle to cause the distal portion to produce a curved tissue path.
  • the pushable dilator can be sufficiently sharp and rigid to pass through tissue when pushed using the needle (e.g., by rotating the needle).
  • a dilator (whether or not sufficiently sharp and rigid to be “pushable”) may be straight, or, according to certain specific embodiments of the invention, may be curved in a manner that will improve manipulation of the dilator during a surgical procedure, e.g., in a manner that will facilitate pushing the dilator through tissue to either produce or follow a particular path of tissue.
  • the external size and shape of a dilator may be suited to produce a tissue path that curves around the arcus tendineus, e.g., to exit the pelvic region by passing through the obturator internus above the arcus tendineus, pass behind the arcus tendineus, and re-enter the pelvic region by passing through the levator ani at a location below the arcus tendineus.
  • the curved dilator may be considered to be a two-dimensional form, in that it the curvature of the dilator can define a two-dimensional plane.
  • a curved dilator may include a curved portion that has a radius of curvature in the range from 0.5 to 1.5 centimeters and a length (measured as the arclength of the curved portion) of from 3 to 5 centimeters.
  • a curved shape or radius of a curved dilator can approximate or match a curved shape or radius of an insertion tool (e.g., a curved distal portion of an insertion tool such as a curved distal needle), and the curves of both a dilator and a curved distal portion of an insertion tool (e.g., needle) may be shaped to mach a tissue path that exits the pelvic area at a location near the ischial spine and above the arcus tendineus by passing through the obturator internus muscle, continues around the areus tendineus, and re-enters the pelvic region below the arcus tendineus by passing through the levator ani muscle.
  • an insertion tool e.g., a curved distal portion of an insertion tool such as a curved distal needle
  • a curved dilator may be used with a curved needle (or other insertion tool) designed to fit within an internal space at a hollow interior of the dilator, with the curved insertion tool and the curved dilator having a size and shape to define a tissue path passing around the arcus tendineus as described.
  • FIG. 1 is a diagrammatic representation of a curved needle insertion tool.
  • the alignment feature causes the dilator to be placed on the needle in a specific alignment, which if the needle and dilator are both curved as discussed above, causes the curve of the needle to be aligned with the curve of the dilator.
  • An example of an alignment and anti-rotation feature is a keyed structure, as will be understood, that includes one or more inter-connecting surfaces and structures between the dilator and the needle to allow the dilator to removably connect to the needle when the two are properly aligned, and then to also prevent rotation between the two when the two are connected.
  • Other mechanical structures will also allow the dilator to be attached at an end of a needle in a manner to produce a desired alignment and to prevent rotation of the dilator relative to the needle.
  • FIG. 4 schematically illustrates a prolapse support device (i.e., implant) 110 for treating vaginal prolapse, and insertion tool 122 .
  • Implant 110 includes end (i.e., “extension”) portions 114 and 116 connected to central support portion 120 .
  • Sutures (optional) 118 extend along the lengths of each of extensions 114 and 116 and are connected to central support portion 118 and extensions 114 and 116 .
  • Rigid, curved dilators (in two dimensions) 112 are attached at each distal end of extension portions 114 and 116 .
  • insertion tool 122 (not to scale) includes handle 124 , shaft 126 , and curved distal portion or “needle” 128 .
  • Needle 128 includes a two-dimensional semi-circular form, and needle 128 along with shaft 126 together are in three dimensions.
  • Needle 128 is designed to engage dilators 112 by fitting inside of a dilator 112 , e.g., inside of internal space 113 of each dilator, so that needle 128 , by use of handle 124 of tool 122 , can be used to push dilator 112 through tissue by rotating handle 124 ; rotation of handle 124 about axis 121 , defined by handle 124 and shaft 126 , rotates curved needle 128 .
  • Curved needle 128 , shaft 126 , and handle 124 are in three dimensions.
  • Curved needle 128 is substantially a partial circle (e.g., half circle) that rotates to define a curved tissue path when handle 124 is rotated about longitudinal axis 121 .
  • an optional protective flexible cover or sheaths that could extend over and contain extension portions 114 and 116 .
  • FIG. 4A shows an end view of tool 122 , illustrating the half-circle shape of curved end 128 , in view of handle 124 .
  • Curved end 128 includes an arclength of approximately 180 degrees, starting at a trailing end 129 that connects to shaft 126 , and extending to needle tip 127 .
  • FIG. 4B illustrates these features of tool 122 when connected to dilator 112 , which is also attached to extension portion 116 of implant 110 .
  • distal ends of extension portions can be attached or engaged with an insertion tool in the form of a needle or in the form a tool comprising a distal curved portion (e.g., needle) with attached shaft and handle, the former needle being capable of being manipulated using a separate tool such as a needle-driver, forceps, or surgical pliers, the latter type of needle being capable of being manipulated using the handle, which will be external to the patient during a transvaginal surgical procedure.
  • a separate tool such as a needle-driver, forceps, or surgical pliers
  • exemplary insertion tools include a small two-dimensional needle that can be manipulated during a transvaginal installation by another surgical tool; a tool having a distal portion comprising a curved needle (including a needle tip), shaft, and handle, that can be used directly to install the implant; a dilator; or another type of tool that can be used to allow ends of an extension portion of an implant to be transvaginally installed in tissue as desired.
  • an attached insertion tool can be a small needle that can be securely attached at distal end of an extension portion of an implant.
  • the needle can be straight or curved (e.g., in two dimensions), and may preferably be sized to be manipulated using a standard surgical grasping instrument such as a pliers, forceps, or needle-passer, and can be can be shaped and sized as desired, such as with a curve and length that facilitate passing the needle through a tissue path that wraps around an arcus tendineus.
  • pre-attached small, two-dimensional curved needle may include a curved portion that has a radius of curvature in the range from 0.5 to 1.5 centimeters and a length (measured as the arclength of the curved portion) of from 3 to 5 centimeters.
  • a distal end of an extension portion of an implant may be attached at a trailing end of the needle. (Attachment at trailing end of a needle or at a leading end of a needle refers to attachment that is within a distance of an end of a needle of 25 percent of the total needle length.)
  • the attached insertion tool e.g., needle
  • the attached insertion tool can optionally include useful features that allow manipulation and placement of the needle as desired to place the implant in a useful position.
  • a needle may include flat portions that allow easy grasping and manipulation with a standard needle-driver, forceps, or pliers.
  • the needle may be plastic or metal.
  • the curve and sizing of the needle can be shaped to match a tissue path that exits the pelvic area at a region of the arcus tendineus, wraps around an arcus tendineus, and re-enters the pelvic region.
  • FIG. 5 schematically illustrates a prolapse support device for treating vaginal prolapse, the device including attached insertion tools in the form of small curved two-dimensional needles having length L and radius of curvature R.
  • Implant 130 includes end portions 134 and 136 connected to central support portion 140 .
  • Sutures 138 extend along the lengths of each of extensions 134 and 136 and are connected to central support portion 140 and extensions 134 and 136 .
  • Attached insertion tools 132 in the form of small curved two-dimensional needles, are attached to distal ends of extensions 134 and 136 .
  • Length L (the arclength of each needle) can be as desired, e.g., from 3 to 5 centimeters.
  • Curvature of radius R can be as desired, e.g., from 0.5 to 1.5 centimeters.
  • Insertion tools 132 are designed to be transvaginally manipulated by a tool such as a needle driver, surgical pliers, surgical forceps, etc., during installation of implant 130 , e.g., according to methods described herein.
  • FIG. 6 schematically illustrates a prolapse support device that includes an implant having two pre-attached insertion tools.
  • Implant 142 includes end portions 144 and 148 connected to central support portion 150 .
  • Sutures 146 extend along the lengths of each of extension 144 and 148 and are connected to central support portion 150 and extensions 144 and 148 .
  • Insertion tools 152 include shaft 156 , handle 154 , and curved distal portion, needles 158 , each needle being attached at a distal end of extension portions 144 and 148 .
  • Each tool 152 includes handle 154 , shaft 152 , curved needle end 158 at a distal end of shaft 152 , and needle tip 160 . Tips 160 are leading edges of curved needles 158 , and each is attached to a distal end of an extension portion 144 or 148 .
  • a surgeon receives the implant product 142 with tools 152 attached; the surgeon installs implant 142 , transvaginally, with support portion 150 being attached to vaginal tissue.
  • the surgeon uses each of tools 152 to place ends of extension portions 146 and 148 bilaterally through tissue in the region of the arcus tendineus, e.g., near the ischial spine.
  • Curved distal end 158 of each tool 152 allows the surgeon to lead a distal end of each extension portion 144 and 148 around the outside of the arcus tendineus and back into the pelvic region at a location below the arcus tendineus, e.g., through the iliococcygeous muscle.
  • This placement can be performed by movement or each tool 152 , the movement including rotation of handle 154 about an axis that includes shaft 156 , to rotate curved distal end 158 , also about the axis of shaft 156 .
  • This can pass tip 160 and a distal end of an extension portion around an arcus tendineus, with the distal end exiting and re-entering the pelvic region.
  • each extension portion 144 and 148 can be disconnected from each tip 160 by cutting the extension portions 144 and 148 near tip 160 of each tool 152 .
  • the needle and tool can be removed from the pelvic region and each extension portion 144 and 148 can be manipulated to adjust and position the extension portion and implant 142 as desired to support vaginal tissue connected to support portion 150 .
  • This can optionally include producing another tissue path to an external location and leading the end of each extension portion 144 and 148 through that tissue path to the external location in the perirectal region such as is illustrated in FIGS. 7 and 9 .
  • each extension portion 144 and 148 can be severed and severed ends can be left at locations within the pelvic floor region without leading extension portions 144 and 148 to an external incision.
  • a kit according to the invention can include an implant and a tool or multiple tools for installation, e.g., with the insertion tool being either removably enjoyable or attached (e.g., permanently) at a distal end of an extension portion of the implant.
  • a kit is illustrated (not to scale) to include a mesh tape implant ( 220 ) for supporting vaginal tissue, insertion tool 200 comprising a distal end having a curved needle, and tunneler device 230 .
  • FIG. 4 includes an illustration of an exemplary insertion tool useful for installing a mesh to pass above the arcus tendineus.
  • Tool 200 (Deschamps Needle) of FIG. 10 is shown as a side view.
  • Tunneler device 230 (e.g., IVS tunneler) includes hollow trocar 232 and flexible plastic plug 234 , as are known.
  • Tool 200 includes handle 202 , shaft 204 having a proximal end connected to handle 202 , shaft 204 connected at a distal end to curved end (e.g., “needle”) 208 .
  • the diameter of the curved needle portion 208 is shown to be 1 inch, meaning that the radius of curvature is about 0.5 inch; other sizes of the curve may also be useful.
  • Curved end 208 defines a two-dimensional curve, and the combination of curved end 208 with shaft 204 together are in three dimensions.
  • tip 210 of curved end 208 can be adapted to allow an end of a mesh implant to be held (removably engaged) by tip 210 .
  • Tip 210 can also be sharpened to allow the tip to be passed through tissue.
  • Tool 200 may be a Deschamps Needle or similar structure having a handle, shaft, and a curved portion at the end of the shaft.
  • a distal end ( 222 ) of mesh implant 220 can be attached to the end. (tip) of curved portion of curved needle 208 of tool 200 .
  • a surgeon can make a vaginal incision to allow transvaginal insertion of curved end 208 of tool 200 , with a distal end 222 of implant 220 attached at the end (tip) 210 of curved portion 208 .
  • Center portion 224 of implant 220 is attached to the vaginal apex to provide support, and each/of ends 222 can be extended bi-laterally through tissue paths that pass through a region of the arcus tendineus, such as through the obturator internus muscle just above the arcus tendineus at the level of the ischial spine.
  • Tunneler device 230 can be used to separately retrieve each of ends 222 of mesh implant 220 and draw ends 222 through a tissue path to an external incision, e.g., an external incision in the perirectal region.
  • the invention contemplates placement of an implant, as described, to treat a condition of vaginal tissue prolapse, by use of transvaginal surgical methods.
  • the present description identifies certain combinations of implants, tools, and procedures, but as will be understood based on the present description, many different variations on the present methods, tools, and procedures will be useful, as will combination of implant, tool, and procedure.
  • an extension portion of an implant can be inserted trough a vaginal incision and a central portion of the implant can be attached to vaginal tissue that is to be supported.
  • Two opposing tissue paths are created from the vaginal tissue to regions of the arcus tendineus, e.g., above the arcus tendineus at a level of the ischial spine, one on each side of the pelvic region.
  • Each end (“extension”) portion of the implant can then be extended through a tissue path and above or below the arcus tendineus, such as through the obturator internus muscle or iliococcygeus, optionally also as close to the ischial spine as possible, using the curved needle.
  • the end portion of the implant is passed around the outside of the white line and passed back into the pelvic region either below or above the white line, either through obturator internus or the iliococcygeus muscle. This location of the mesh end is illustrated in FIGS. 7, 7A, 8, 9, and 9A .
  • the end of the mesh thus passes back into the pelvic floor and can be subsequently passed through a tissue passage that is created below that pelvic floor location, to an incision made external to the rectal region at each buttock (e.g., 2 to 3 centimeters lateral and 2 to 3 centimeters posterior to the anus).
  • a tissue passage that is created below that pelvic floor location
  • Methods of the invention can involve placement of an implant and extension portion using a system as shown in FIG. 4 .
  • Distal curved portion 128 of tool 122 is engaged with interior space 113 of dilator 112 , and tool 122 can be inserted transvaginally and rotated to produce a tissue path in a region of the arcus tendineus.
  • Tool 122 then engages the second dilator to make a second opposite tissue path, transvaginally.
  • Each extension portion can be adjusted as desired, and tissue support portion 120 can be attached to vaginal tissue and adjusted.
  • a tissue path can be produced transvaginally using tool 122 , as a first step, then dilator 112 can be engaged with distal end 128 after formation of the tissue path. After engaging dilator 112 and distal end 128 , tool 122 can be counter-rotated to cause the dilator to be pulled back through the tissue path. The extension portion and tissue support portion 120 can then be adjusted.
  • Methods of the invention include variations that advantageously do not require any external incision such as two incisions perirectal incisions.
  • an extension portion of an implant can be inserted through a vaginal incision and a central portion of the implant attached to vaginal tissue that is to be supported.
  • Opposing tissue paths are created starting at the vaginal tissue and extending to opposite locations at regions of the arcus tendineus, e.g., above the arcus tendineus at the level of the ischial spine.
  • Each end portion of the implant can then be extended through one of the opposing tissue paths and through obturator internus muscle, as close to the ischial spine as possible.
  • the end portion of the implant is passed (wrapped) around the outside of the white line and passed back into the pelvic region below the white line, through the iliococcygeus muscle.
  • the end of the mesh thus passes back into the pelvic floor.
  • the end portion can be cut off, e.g., within the pelvic region, and the severed end left in that internal position of the anatomy.
  • the end portion may optionally be secured using a suture.
  • the severed end portions of the implant will remain in place within the defined tissue path and will the implant will support the vaginal tissue.
  • FIG. 7 illustrates an installed mesh tape implant 220 (e.g., as shown in FIG. 10 ) that includes a central support portion ( 224 ) secured to tissue of the vaginal apex,
  • Each of two distal ends 222 of extension portions 221 of implant 220 extends bilaterally to pass above each arcus tendineus ( 6 ), near each ischial spine ( 8 ).
  • Each of the two distal ends 222 of extension portions 221 of implant 220 then passes thorough the iliococcygeus muscle (not shown), below the white line ( 6 ), back to the pelvic floor region and then through two tissue paths, each path extending to an external incision ( 70 ) in the perirectal region.
  • FIG. 7A illustrates an alternate embodiment of an installed mesh tape implant 220 (e.g., as shown in FIG. 10 ) that includes a central support portion 224 secured to tissue of the vaginal apex.
  • Each of two extension portions 221 of implant 220 extends bilaterally to pass above each arcus tendineus ( 6 ) near each ischial spine ( 8 ).
  • Each of the two extension portions 221 of implant 220 then passes thorough the iliococcygeus muscle (not shown) below the white line ( 6 ) and back to the pelvic floor region.
  • Each of the two extension portions 221 of implant 220 is severed to create an end of the extension portion located within the pelvic floor and extension portions 221 are not extended through tissue paths to any external incision.
  • FIG. 8 illustrates another view of an installed mesh tape implant, such as implant 220 shown in FIG. 10 .
  • FIG. 8 looks in a direction down into the pelvic cavity, such as from a position in the abdomen.
  • pubic bone 80 For reference are shown pubic bone 80 , bladder 82 , obturator internus muscle 84 , and iliococcygeous muscle 86 .
  • a central support portion 224 of a mesh implant 220 is secured using sutures (not shown) to tissue of the apex of vagina 2 .
  • Each of the two distal ends 222 of extension portions 221 of implant 220 are extended bilaterally and passed through opposing tissue paths above each arcus tendineus ( 6 ), near each ischial spine ( 8 ), e.g., through obturator internus muscle 84 .
  • the far portions and distal ends 222 of the extension portions 221 of implant 220 are not shown in FIG. 8 .
  • These far portions of extension portions 221 may extend through alternate tissue paths, such as back into the pelvic region by passing through iliococcygeous muscle 86 at a location below arcus tendineus 6 , then either severed at a location within the pelvic floor region or passed to an external incision.
  • FIG. 9 illustrates still another view of an exemplary installed mesh tape implant 220 that includes central support portion 224 secured to tissue of the vaginal apex.
  • FIG. 9 is a view from exterior of the patient, facing the vagina and anus ( 90 ).
  • Each of two distal ends 221 of the implant 220 extends bilaterally to pass above each arcus tendineus 6 near each ischial spine 8 , around the arcus tendineus 6 , and then thorough the iliococcygeus muscle (not shown) below the white line 6 and back to the pelvic floor region. From there each extension portion 221 passes through a tissue path extending to an external incision ( 70 ) in the perirectal region.
  • FIG. 9A illustrates an alternate embodiment of an installed mesh tape implant that includes a central support portion 224 secured to tissue of the vaginal apex.
  • FIG. 9 is a view from exterior of the patient, facing the vagina and anus ( 90 ).
  • Each of two extension portions 221 of implant 220 extends bilaterally to pass above each arcus tendineus 6 near each ischial spine 8 .
  • Each of the two extension portions 221 of the implant 220 then passes around arcus tendineus 6 and then through the iliococcygeus muscle (not shown) below the white line 6 back to the pelvic floor region.
  • Each of the two ends of the implant is severed to create an end that remains internally within the pelvic floor, and the end portions are not extended through tissue paths to external incisions in the perirectal region.

Abstract

Described are implants, tools, and related methods, for use in pelvic surgery to treat conditions such as prolapse, including embodiments of methods that involve a tissue path above the arcus tendineus.

Description

    PRIORITY CLAIM
  • The present non-provisional patent Application claims priority under 35 USC §119(e) from United States Provisional Patent Applications having Ser. No. 60/702,704, filed on Jul. 26, 2005, by James E. Cox and titled CONNECTORLESS IMPLANT SYSTEM; 60/702,705, filed on Jul. 26, 2005, by Guillermo Wiley Davila et al. and titled TRANSVAGINAL SYSTEM FOR APICAL SUPPORT; and 60/702,700, filed on Jul. 26, 2005, by James E. Cox et al. and titled METHODS AND SYSTEMS FOR TRANSVAGINAL TREATMENT OF PROLAPSE, wherein the entirety of these provisional patent applications are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • Described herein are features of surgical articles, surgical methods, and surgical tools, for use in the field of pelvic surgery, e.g., to install support devices for use in treating vaginal prolapse.
  • BACKGROUND
  • Medical conditions involving pelvic prolapse are conditions of great importance. An aging population can be prone to such conditions. Pelvic prolapse develops when intra-abdominal pressure, muscle failure, a surgical procedure such as a hysterectomy, or other factors, allow or cause a tissue of a pelvic organ such as the vagina to become displaced. Within the general category of pelvic organ prolapse, specific types include vault prolapse (apical); cystocele (anterior); rectocele and enterocele (posterior); and combinations of these.
  • Various techniques have been designed to correct or ameliorate prolapse and prolapse symptoms, with varying degrees of success. Nonsurgical treatments involve measures to improve the factors associated with prolapse, including treating chronic cough, obesity, and constipation. Other nonsurgical treatments may include pelvic muscle exercises or supplementation with estrogen.
  • A variety of surgical procedures have also been attempted for the treatment of prolapse. See for example U.S. patent application Ser. No. 10/834,943, entitled “Method and Apparatus for Treating Pelvic Organ Prolapse,” filed Apr. 30, 2004, and Ser. No. 10/306,179, entitled “Transobturator Surgical Articles and Methods,” filed Nov. 27, 2002, the entireties of each of these two patent applications being incorporated herein by reference. Such patent applications describe articles and methods for treating pelvic organ prolapse by use of a support member for supporting specific tissue. Application Ser. No. 10/834,943, for example, discusses a support member that includes a central tissue support portion and two end (extension) portions, and related methods for implantation. The central tissue support portion can be attached at tissue of a vaginal vault. The end portions of the support member are then positioned through respective tissue pathways extending to an external incision at the perirectal region, to place the support member in a therapeutic position.
  • Methods of supporting vaginal tissue to treat vaginal prolapse can be differentiated in terms of the location of implanted materials or anatomical tissue used to support the vaginal tissue. One current method of treating posterior vaginal tissue prolapse involves the use of an intravaginal slingplasty (“IVS”) tunneler device. Methods of treating prolapse using an IVS tunneler involve supporting vaginal tissue by attaching a portion of a surgical implant to vaginal tissue and passing another portion of the implant through the iliococcygeus muscle below the white line, for support. A different technique, known as sacrospinous ligament fixation, involves supporting vaginal tissue by attachment to the sacrospinous ligaments. Both of these methods have drawbacks, such as not providing completely correct anatomical support for the vagina. Attaching vaginal tissue to the sacrospinous ligaments can pull the vagina down toward the pelvic floor. The use of an IVS tunneler to pass an implant through the iliococcygeous muscle allows for support from a location higher up in the anatomy, but still not an anatomically correct location.
  • SUMMARY
  • The invention relates to transvaginal methods of treating posterior vaginal prolapse, and surgical devices. Embodiments relate to methods, tools, and surgical systems useful for transvaginal placement of an implant (e.g., a synthetic mesh implant or an implant that contains a combination of synthetic and biologic materials) in a position to support posterior tissue of the vagina, wherein the implant passes bi-laterally through opposing tissue paths that each include passage at a region of the arcus tendineus, e.g., near the ischial spine.
  • Some embodiments of methods may involve an external incision at a perirectal region, to place an extension portion of an implant, while alternate embodiments to not require and can avoid an external incision. The implant can be introduced to the pelvic region transvaginally; transvaginally attached to tissue of the vaginal vault for support; and then distal ends of the implant can be passed bilaterally near a region of each arcus tendineus (e.g., near both of the patient's ischial spines), as described, using a transvaginal procedure.
  • The tissue path through a region of the arcus tendineus can result in benefits including proper anatomical positioning of the supported vaginal tissue, and fixation of the implant in tissue near the arcus tendineus due to tissue ingrowth. Additionally, exemplary transvaginal methods can allow for the location of extension portions to be adjusted by movement of the extension portion extending through the tissue path, e.g., through a tissue path that surrounds the arcus tendineus.
  • According to certain embodiments an implant can be used to treat vaginal vault prolapse. The support member can include a tissue support portion that can be attached to tissue of the vaginal vault and two end portions attached to the tissue support portion. The implant can be used to place vaginal tissue in a therapeutic position for treatment of vaginal vault prolapse by attaching the tissue support portion to tissue of the vaginal vault, and attaching the end portions to separate locations for positioning or supporting the prolapsed tissue.
  • Exemplary implants, methods, tools, and systems provide anatomical support to treat vaginal prolapse (e.g., vaginal vault prolapse, enterocele, and rectocele) by using a supportive implant attached to vaginal tissue, that passes from posterior vaginal tissue to a location in a region of the arcus tendineus (“white line”), e.g., near the ischial spine. The implant can pass from the point of attachment at the vaginal tissue, through a tissue path that includes passage through tissue at the immediately anterior edge of the ischial spine and at the level of the ischial spine near the connection of the ischial spine to the arcus tendineus, and above or below the arcus tendineus.
  • As used herein, the terminology that refers to positions “above” the white line refers to anatomy that includes the obturator internus muscle, and references to positions “below” the white line refer to anatomy that includes the iliococcygeus muscle. Stated differently, embodiments of the invention involve a tissue path that is defined to include a curved-rectangular-shaped area above and below the curved arcus tendineus. The region includes a specific region having a height extending from 2 inches above to 2 inches below the arcus tendineus, and a length starting at the ischial spine and extending 3 centimeters to the anterior of the ischial spine.
  • In one aspect, the invention relates to a method of supporting posterior vaginal tissue. The method includes: providing an implant comprising a tissue support portion and an extension portion extending from the tissue support portion, creating a vaginal incision, transvaginally contacting the support portion with posterior vaginal tissue, transvaginally producing a tissue path between the position of the tissue support portion and a region of the arcus tendineus, and transvaginally extending the extension portion through the tissue path.
  • In another aspect, the invention relates to a pelvic implant assembly that includes: an implant comprising supportive portions comprising a tissue support portion, and elongate extension portions extending from of the tissue support portion; and an insertion tool at a distal end of an extension portion, the insertion tool comprising a curved portion sized and shaped to be used in a transvaginal procedure to define a tissue path that exits the pelvic floor region in a region of the arcus tendineus, partially extends around an arcus tendineus, and re-enters the pelvic floor.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates anatomy relevant to the invention, including specific pelvic anatomy.
  • FIG. 2 illustrates anatomy relevant to the invention, including specific pelvic anatomy.
  • FIG. 3 illustrates anatomy relevant to the invention, including specific pelvic anatomy, and also exemplifies an implant according to the invention.
  • FIG. 4 illustrates an exemplary system of the invention including an exemplary tool and an exemplary implant with attached dilators.
  • FIG. 4A is an end view of an exemplary tool.
  • FIG. 4B is an end view of an exemplary tool with attached dilator of an implant.
  • FIG. 5 illustrates an exemplary implant according to the invention.
  • FIG. 6 illustrates an exemplary implant assembly according to the invention, including an implant and attached insertion tools.
  • FIG. 7 illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 7A illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 8 illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 9 illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 9A illustrates an exemplary implanted pelvic implant according to the invention.
  • FIG. 10 illustrates an exemplary kit or system according to the invention, including a Desehampes Needle, an implant, and a tunneler device.
  • DETAILED DESCRIPTION
  • According the invention, surgical implants can be used to treat conditions of vaginal prolapse. Also contemplated herein are various features of surgical implants, surgical tools, systems that include implant and tool, and surgical methods. The implants and tools are useful for treating conditions of vaginal prolapse including vaginal vault prolapse, but will also be appreciated to be useful for treating other conditions of pelvic tissue prolapse.
  • In general, the invention relates to methods, tools, and systems useful for attaching one portion of a surgical implant to pelvic tissue such as vaginal tissue and passing another portion of the implant through a tissue path that includes tissue in the region of the arcus tendineus or “white line,” preferably near the ischial spine.
  • The location of this tissue path passing through a region of the arcus tendineus or “white line” can result in improved anatomical correctness of the position of supported vaginal tissue. The location in the region of the white line can provide a proper axis for supported vaginal tissue, higher than support provided by alternate methods of treating vaginal prolapse such as those that involve sacrospinous ligament fixation or use of the IVS tunneler, which alternate methods would typically produce a tissue path more directly through the buttocks. A location in the region of the arcus tendineus, e.g., above the arcus tendineus, does not cause vaginal tissue to be pulled down toward the pelvic floor as with attachment to the sacrospinous ligaments. Also, a better vaginal length can result compared to the use of an IVS tunneler, because the support is located closer to the ischial spine.
  • Also advantageously, a tissue path can be one that wraps around the outside portion (relative to the region of the pelvic floor) of the arcus tendineus, meaning that an extension portion of an implant exits the pelvic region near the arcus tendineus (either above or below the arcus tendineus), continues along a path that wraps or bends around the white line, then re-enters the pelvic region on the other side of the white line; i.e., below or above the arcus tendineus, whichever is opposite of the direction of entry. The tissue path can include a relatively sharp turning radius to place the extension portion near the arcus tendineus. By extending around the white line, the extension portion contacts tissue that surrounds the white line and can become ingrown into that tissue. This ingrowth can provide fixation of the extension portion into the tissue. During the procedure the placement of the extension portion and implant can be adjusted by manipulating the extension portion from the pelvic region side, after passing the extension portion around the arcus tendineus. Specifically, the extension portion will include two portions within the pelvic region, and those two portions can be manipulated to adjust the position of one or more of the extension portion, a central portion of an implant, and tissue attached to a central portion of the implant.
  • FIG. 1 schematically illustrates a top view of anatomy of vagina and nearby tissue. Vagina 2 and cervix 4 are schematically illustrated in relation to arcus tendineus or “white line” 6, ischial spine 8, and uterosacral ligaments 10. An exemplary region of a tissue path according to the invention, a region of the arcus tendineus, 6, is illustrated as an approximately-rectangular regions 12 (shown by dashed lines—one on each side of the pelvic region). Each region 12 includes area above and below arcus tendineus, 6, starting at ischial spine 8 and extending in an anterior direction along the length of the arcus tendineus. Although obturator internus and iliococcygeus muscles are not shown in FIG. 1, region 12 is located to include or be adjacent to the obturator internus muscle (above the white line) and the iliococcygeus muscle (below the white line); a tissue path that passes through region 12 also passes through obturator internus muscle or iliococcygeous muscle.
  • A preferred example of a region of the arcus tendineus, e.g., as illustrated as region 12, can be defined as a curved-rectangular-shaped area defined to include a region that extends 2 centimeters above and 2 centimeters below (e.g., 1 centimeter above and 1 centimeter below) the arcus tendineus and that has a length starting at the ischial spine and extending in an anterior direction along the arcus tendineus, e.g., a distance of up to about 3 centimeters anterior of the ischial spine (e.g., up to about 1 centimeter anterior to the ischial spine). A particularly preferred tissue path can be very near or as close as possible to the ischial spine and either above or below the arcus tendineus, such as through tissue at the immediately anterior edge of the ischial spine and at the level of the ischial spine near the connection of the ischial spine to the arcus tendineus; dimensions can be 0.5 or 1 centimeter above or below the arcus tendineus, and 0.5 or 1 centimeter anterior to the ischial spine along the arcus tendineus.
  • FIG. 2, a top view of pelvic features, schematically illustrates sacrospinous ligament 11, arcus tendineus 6, ischial spine 8, sacrum 16, and exemplary tissue path 14 illustrated as circular line 14 passing around an outside of arcus tendineus 6, i.e., wrapping around arcus tendineus 6. This wrapped configuration places an implant material near the arcus tendineus, e.g., in surrounding tissue such as surrounding muscle tissue, which allows for ingrowth of tissue into the implant material located at path 14, and fixation of that implant material at that location. FIG. 2 illustrates an example of a circular tissue path, 14, that passes above arcus tendineus 6 near (e.g., within 2 centimeters, such as within 1 or 0.5 centimeters) ischial spine 8. Path 14 includes an arrow showing a direction of a needle (not shown) following path 14, starting below arcus tendineus 6, exiting the pelvic region by passing below the arcus tendineus and through the iliococcygeus muscle (levator ani) (not shown), passing around arcus tendineus 6, and then passing back into the pelvic region by passing above the arcus tendineus 6 through the obturator internus muscle (not shown).
  • FIG. 2 illustrates what can be referred to as a “bottom-up” technique for passage of an end portion or extension portion of implant material through a region of the arcus tendineus. The bottom-up method inserts a distal end of an extension portion of an implant below the arcus tendineus and through the iliococcygeus muscle; the implant extension portion distal end is then passed around the back or outside of the anus tendineus to a location above the arcus tendineus, and then through the tissue above the arcus tendineus (i.e., through the obturator internus muscle) where the implant end then re-enters the region of the pelvic floor.
  • Alternately, a tissue path as illustrated in FIG. 2 may be produced using a “top-down” method. As opposed to the bottom-up method specifically illustrated at FIG. 2, a top-down method inserts the implant extension portion distal end above the arcus tendineus through the obturator internus muscle, wraps the extension portion around the arcus tendineus, then the extension portion re-enters the region of the pelvic floor below the arcus tendineus by passing through the iliococcygeus muscle. A top-down method may be a preferred method because top-down methods allow a needle tip to extend away from the bladder when passing through the obturator internus muscle. In a top-down method, the implant extension distal end, after wrapping around the arcus tendineus and re-entering the pelvic floor region (i.e., through the iliococcygeus muscle), may be led through one of various tissue path options. For example, the end extension may re-enter the pelvic floor region and then extend to and terminate at a location internal to the pelvic region. The distal end of the extension portion could be sutured, e.g., using a “stay suture,” to maintain placement within the pelvic floor. This method advantageously does not require an external incision for manipulating the extension portion. Another variation of the method is to use a tissue path as mentioned, but that continues through the pelvic region and then to and through an external incision such as through the buttock and then through an external incision, wherein the extension portion can be adjusted and cut off to a desired length.
  • As illustrated in FIG. 3, embodiments of the invention involve the use of a single mesh bridge (e.g., a uniform mesh strip) implant between tissue paths described herein, above the white line and optionally and preferably near the ischial spines, to repair vaginal vault prolapse. Optionally, if desired, a mesh strip implant may use a modified middle section with denser construction (e.g., use of a biologic material for a middle section, 22) to hold sutures better than standard mesh. A vaginal vault repair results in an anatomically correct “pear” shape to the distal vagina, with the vaginal vault correctly positioned between the ischial spines.
  • Referring to FIG. 3, this figure illustrates a top view of the anatomy of FIG. 1 including a mesh support implant 20 installed according to an exemplary tissue path described herein. Implant 20 includes central (tissue support) portion 22 sutured to the apex of vagina 2 by sutures 18 (designated as “x”s). Implant 20 also includes two end portions, 24 and 26, extending bilaterally from tissue support portion 22. Each of end portions 24 and 26 is illustrated to pass from apex of vagina 2, laterally toward arcus tendineus 6. Each end portion 24 and 26 passes above arcus tendineus 6, near ischial spine 8—i.e., through tissue at the immediately anterior edge of ischial spine 8 and at the level of the ischial spine near the connection of the ischial spine to the arcus tendineus—through the obturator internus muscle (not shown), around arcus tendineus 6. In FIG. 3, extension portions 24 and 26 are shown to continue through tissue below the arcus tendineus (i.e., through the iliococcygeus muscle, not shown) and back into the pelvic floor region.
  • Referring still to FIG. 3, sections 21 and 23 of end portions 24 and 26 are located internal to the pelvic floor region. During a surgical implantation procedure, these portions can be manipulated by grasping manually or with a surgical instrument such as a forceps, needle-passer, or pliers, to adjust the position of end portions 24 and 26, as well as support portion 22 and overall implant 20.
  • The invention also relates to implants, tools, and kits, that may be used according to methods described herein, and that may also be useful for treating conditions other than vaginal prolapse, e.g., other types of pelvic tissue prolapse. In general, implants that may be useful according to methods described herein can include those types of implants known for use to treat vaginal prolapse, and similar implants. Exemplary implants can be in the form of a biocompatible mesh material such as a mesh strip made of a single uniform length of mesh, or, alternately, can be a multi-portion implant that includes a support portion for attachment to pelvic (e.g., vaginal) tissue connected to end portions or extensions. Embodiments include a length of mesh strip of generally uniform thickness and width, as well as implants having distinct or discernible sections of different sizes, materials, or mechanical properties. Other exemplary embodiments include a tissue support portion of a biologic material and extension portions of synthetic mesh material.
  • Exemplary implants may be a mesh strip such as mesh strips and multi-component implants illustrated in the accompanying figures. As illustrated, exemplary implants may consist of a strip of uniform thickness and width, as well as implants that include portions of different sizes, shapes, and materials, for connecting to tissue and for supporting tissue. A tissue support portion may be of a biologic material or a synthetic (e.g., mesh) material. Attached to a tissue support portion can be one, two, or more, extensions (or “extension portions” or “end portions”) shaped and sized to extend from the point of attachment with the support portion of the implant to another location of the anatomy. Each extension may be an elongate material that is biologic or synthetic, e.g., an elongate synthetic mesh attached directly to the support portion.
  • Various implant products are available commercially for treating prolapse conditions, e.g., from American Medical Systems Inc., of Minnetonka Minnesota. Examples of such products include: the line of PERIGEE™ products for treatment of cystocele, from American Medical Systems, Inc.; the APOGEE™ product for treating enterocele, rectocele, and vaginal vault prolapse, also available from American Medical Systems Inc.; as well as products for CAPS procedures (combined-prolapse-repair-with sling) for treating cystocele and stress urinary incontinence.
  • Examples of implants that can be used or modified for use according to the present description are described, e.g., in US application number 2004/0039453, “Pelvic Health Implants and Methods,” (describing implants useful for treating multiple pelvic disorders) having Ser. No. 10/423,662, and filed on Apr. 25, 2003; US application number 2005/0245787, “Method and Apparatus for Treating Pelvic Organ Prolapse,” having Ser. No. 10/834,943, and filed on. Apr. 30, 2004; U.S. patent application Ser. No. 11/347,063, filed Feb. 3, 2006, entitled “Pelvic Implants and Related Methods; U.S. patent application Ser. No. 11/398,368, filed Apr. 5, 2006, entitled “Articles, Devices, and Methods for Pelvic Surgery”; and U.S. patent application Ser. No. 11/243,802, filed Oct. 5, 2005, entitled “Method for Supporting Vaginal Cuff” the entireties of each of these being incorporated herein by reference.
  • Exemplary implants can include a tissue support portion for placing in contact with tissue to be supported, and one or more “extension” portions (or “end portions”), the tissue support portion being useful to support pelvic tissue such as vaginal tissue (anterior, posterior, apical, etc). The tissue support portion can be sized and shaped to contact the desired tissue when installed. A tissue support portion that is located between two or more extension or end portions is sometimes referred to herein as a “central support portion.”
  • Dimensions of an implant or a portion of an implant can be as desired and useful for any particular installation procedure, treatment, or combination of treatments, and to support a specific tissue, type of tissue, or multiple tissues (e.g., bladder, vagina, urethra, etc.), Exemplary dimensions can be sufficient to allow the tissue support portion to contact tissue to be supported and to allow one or more extension portion to extend from the tissue support portion to a desired anatomical location, e.g., through a tissue path through a region of the arcus tendineus, as described.
  • A tissue support portion can be sized and shaped to an overall area for contacting tissue being supported, and can depend on the condition being treated, e.g., vault prolapse, enterocele, rectocele, or a combination of these. The tissue support portion is of sufficient size and shape to at least partially surround or otherwise be in contact to support prolapsed tissue. A tissue support portion can optionally be of a width that is greater than a width of an extension portion. An increased width of a tissue support portion may take the form of one or two lateral extensions that extend the width of the tissue support portion in at least one direction, beyond the width of an extension portion. The shape of the tissue support portion can also be varied, depending on the intended application and treated condition, and may be square, rounded, angled, rectangular, etc. Exemplary widths of a tissue support portion, measured laterally (i.e., perpendicular to lengths of extension portions), can be in the range from 1 to 8 centimeters, such as from 2 to 6 centimeters. Generally, exemplary lengths of a tissue support portion can be up to 8 centimeters, such up to about 4 centimeters.
  • Extension portions are elongate pieces of material that extend from the tissue support portion and are integral with or connected to the tissue support portion. Extension portions are useful to attach to other anatomical features and thereby provide support for the tissue support portion and the supported tissue. One or multiple (e.g., one, two, or four) extension portions can extend from the tissue support portion as elongate “ends,” “arms,” or “extensions,” that are used to attach to other anatomy. Extension portions extending from a tissue support portion in contact with posterior vaginal tissue, can be extended through a tissue path as described herein, passing through a region of the arcus tendineus such as above the arcus tendineus.
  • A width of an extension portion can be a width useful for implanting the implant and for providing desired strength and fixation properties during and after implantation and optional tensioning of the sling. Typical widths of an extension portion can be in the range from 0.5 to 3 centimeters, e.g., from 0.8 to 2 centimeters, such as from 0.8 to 1.5 centimeters. Extension portions can typically have a uniform or substantially uniform width along the length, normally not varying by more than about 25 percent of the average width along the length of the installed portion of the extension portion. A length of an extension portion can be as desired to extend from a tissue support portion installed at a desired pelvic tissue location, through a tissue path of a desired length, e.g., from a tissue support portion installed at a vaginal tissue, to a region above the arcus tendineus, optionally back into the pelvic cavity, and optionally further passing through the buttock to an exterior incision external to the buttock.
  • An example of a particular type of pelvic implant is the type that includes supportive portions including or consisting of a central support portion and two elongate extension portions extending from the central support portion. The term “supportive portions” refers to portions of an implant that function to support tissue after the implant has been implanted, and specifically includes extension portions and a tissue support portion, and does not include optional or appurtenant features of an implant such as a sheath, dilator, attached or engaged insertion tool, or other connected tools or implantation aids. FIGS. 4, 5, and 6, for example, illustrate implants having supportive portions consisting of a tissue support portion and two elongate extension portions.
  • According to certain embodiments of implants, various features can be incorporated into a useful implant to facilitate installation of a device during a surgical procedure. For instance, a suture may be attached to an implant, along a length of an extension portion, for use in adding tension or in positioning the implant or a portion (e.g., extension) of the implant. Alternately or in addition an exemplary implant may include a removable sheath such as a flexible plastic, transparent elongate tube that can cover extension portions of an implant to allow a surgeon to apply tension or pressure on the sheath to indirectly apply pressure or tension to the extension portion, for placing or adjusting the location of the implant.
  • An implant can be installed according to the present description by use of standard surgical instruments, or by use of instruments that are designed or particularly useful for placing an extension portion through a tissue path as described, e.g., in a region of the arcus tendineus, such as above the arcus tendineus. Generally, an insertion tool may include a portion for creating a tissue path, that portion being curved or straight, with exemplary embodiments including a curved portion of a sized and shaped (e.g., length and curvature) that will be useful to form a tissue path as described herein, in a region of the arcus tendineus and preferably wrapping around the arcus tendineus, to lead a distal end of an extension portion at least partially through a tissue path that wraps around the arcus tendineus. An exemplary length (measured as the circumferential arclength of the curved portion) of a curved portion can be from 3 to 5 centimeters, and an exemplary radius of curvature of a curved portion may be, e.g., in the range from 0.5 to 1.5 centimeters.
  • Exemplary geometric forms of a curved portion can be a form of a partial circle, such as a half circle. The partial circle is arranged to be in a plane that does not include a line defined by a longitudinal axis of a shaft. With this configuration, the curved portion can be located to define a partial circle having the shaft of the tool (and a longitudinal axis of the shaft) as a center of the circle. The curved portion can then engage tissue and be rotated around the shaft and longitudinal axis by rotation of the handle about the longitudinal axis, to cause the curved portion to define a circular tissue path. The partial circle can have a relatively uniform radius of curvature, such in the range from 0.5 to 1.5 centimeters (e.g., from 0.7 to 1.2 centimeters), extending over an arclength that traverses from 90 to 270 degrees, e.g., from 170 to 190 degrees, about 180 degrees. This arclength, when measured as the circumference of the partial circle, can be, e.g., from 3 to 5 centimeters.
  • An example of a useful insertion tool is a small curved needle attached at a distal end of an extension portion, which can be manipulated using a surgical instrument such as a forceps or pliers. The small curved needle can consist of a single length of curved needle material, e.g., metal or plastic, attached at a distal end of the extension portion. The needle may be considered to be a two-dimensional form, in that it the curvature of the needle can define a two-dimensional plane. The small curved needle may be manipulated transvaginally and passed through tissue in a region of the arcus tendineus, preferably near the ischial spine. The needle is curved to exit the pelvic region, wrap around the ischial spine, and then lead the extension portion back into the pelvic region to cause the extension portion to follow a tissue path that wraps around the arcus tendineus. The needle may then be removed by cutting the extension portion and the position of the extension portion may be adjusted by manipulation of portions of the extension portions that are located within the region of the pelvic floor.
  • Another example of a tool useful for placing an end portion of an implant transvaginally is a small three-dimensional looped needle such as a Deschamps needle or a similar needle that can be introduced transvaginally and that can then be used to pass an end portion of an implant through a tissue path in a region of the arcus tendineus, e.g., at the level of the ischial spine. The tool can be considered to include a shaft and curved end portion that exist in three dimensions, with the shaft defining a longitudinal axis and the curved end portion originating from that axis and extending in two additional directions. In use, an end portion of an implant may be attached to a tip of a curved distal portion of the tool and passed through tissue of a region of the arcus tendineus using the curved tip, transvaginally. For example, the curved distal end portion can be inserted transvaginally, and the handle can be rotated to rotate the curved distal end portion to define a circular tissue path. The needle is curved to exit the pelvic region, wrap around the arcus tendineus, and then lead the extension portion back into the pelvic region to cause the extension portion to follow a tissue path that wraps around the arcus tendineus. Optionally, according to certain exemplary methods, an additional surgical tool such as a tunneler (e.g., the IVS Tunneler device available commercially from Tyco) can be inserted through an external incision (e.g., in a perirectal region) into the pelvic region, attached to a distal end of the extension portion, and then removed to lead the extension portion of the implant from the pelvic region to an external location.
  • An insertion tool or tools (e.g., Deschamps needle, or a small needle to be manipulated by a standard operating room tool such as a needle-driver) may engage a distal end of an extension portion of an implant by any useful engagement configuration. The engagement may be a permanent attachment or removable engagement, as desired.
  • According to certain embodiments of the invention, an insertion tool may be attached to the implant at a distal end of an extension portion. The term. “attach,” when used with regard to an end portion attached to an insertion tool, will refer to engagement configurations that are not easily removable, such as in an a manner designed to be used during a surgical implantation method and that would normally be removed only by cutting the extension portion of the implant, as opposed to releasing (e.g., un-threading) the implant from the insertion tool. Examples of types of attachment mechanisms include attachment by adhesive such as a pressure sensitive adhesive, a structural adhesive, a two-part reactive adhesive such as an epoxy adhesive, etc.; a tight knot using thread or suture material that would not be easily untied during a surgical installation procedure; a non-removable mechanical interaction between the insertion tool and the implant portion such as by permanently threading the implant portion through an eye, eyelet, slot, or hole in the tool so the end portion is not easily removed; a metal or plastic mechanical attachment such as a metal crimp at the end of the insertion tool; a polymeric attachment such as the use of a heat-shrinkable polymeric sheath; attachment by a molding manufacturing process such as by injection molding or insert molding a plastic dilator or plastic needle to a distal end of an extension portion; or any other mechanical or adhesive type of permanent or semi-permanent attaching mechanism. In contrast to an attachment, examples of types of removable engagement mechanisms include use of a loose knot that is easily untied during a surgical implantation procedure; an threaded dilator that removably engages a threaded needle tip for easy engagement and dis-engagement by threading and un-threading; and threading a distal end of an extension portion through an aperture (e.g., eye or eyelet) of an insertion tool such as a needle or a curved distal portion of a tool.
  • Attaching an insertion tool (e.g., dilator, needle, etc.) to a distal end of an extension portion of an implant eliminates the need for a surgeon to make that connection, which reduces preparation of the implant before or during surgery. The term “pre-attached” refers to an implant that includes an insertion tool attached to the implant as the implant is commercially supplied to a surgeon. The pre-attached device can be manufactured for distribution and sale in a condition where only minimal preparation (if any at all) needs to be performed by the surgeon prior to surgical implantation. Minimal preparation may include modification to size or shape of a portion of an implant (e.g., by trimming), or removing loose material or loose pieces, but does not include a step of creating a direct attachment between a portion of the implant and an insertion tool that will allow the portion of the implant to be placed or led through a tissue path.
  • Thus, embodiments of optional features of implants include an insertion tool that is attached e.g., pre-attached, or alternately is removably engaged, at a far (i.e., distal) end of an extension portion of an implant, the tool being a structure that facilitates installation of the extension portion and implant by being of a size, shape, rigidity, and overall design, to be capable of being used transvaginally to create a tissue path that passes through tissue in a region of the arcus tendineus, optionally and preferably wrapping around the arcus tendineus. Examples of insertion tools that may be either attached or removably engaged to a distal end of an extension portion include: a tip (distal end) of an extension portion that includes an attached rigid tip or “dilator,” optionally designed to cooperate and removably engage an end of another insertion tool for use together to create a tissue path during installation of an implant; a distal end of an extension portion that is permanently attached to an insertion tool in the form of a curved distal needle portion and a shaft and proximal handle portion, or another tool that can be inserted transvaginally to manipulate an extension portion of an implant during installation; and a distal end of an extension portion that is permanently attached to an insertion tool such as a small needle that can be manipulated by a grasping tool such as a needle driver, a forceps, or a pliers, etc., to manipulate an extension portion of an implant during transvaginal installation.
  • As one exemplary design, an implant may include a rigid (e.g., plastic), pushable dilator attached at a distal end of an extension portion, the dilator including a sharp tip at a first end and an opening at an opposing end, the opening designed and adapted to fit and removably engage an end of an insertion tool such as a needle. The pushable dilator can be designed to fit the leading edge of an insertion tool such as a long needle having a handle and a distal portion with a tip adapted to fit and removably engage the pushable dilator. The dilator can engage the end of the insertion tool and may be pushed or pulled by the insertion tool through tissue to either follow or produce a path in the tissue, such as by rotating the handle to cause the distal portion to produce a curved tissue path. To produce a path in the tissue by pushing the dilator through the tissue, the pushable dilator can be sufficiently sharp and rigid to pass through tissue when pushed using the needle (e.g., by rotating the needle).
  • A dilator (whether or not sufficiently sharp and rigid to be “pushable”) may be straight, or, according to certain specific embodiments of the invention, may be curved in a manner that will improve manipulation of the dilator during a surgical procedure, e.g., in a manner that will facilitate pushing the dilator through tissue to either produce or follow a particular path of tissue. Optionally for use with methods described herein with a tissue path in the region of the arcus tendineus, e.g., that wraps around the arcus tendineus, the external size and shape of a dilator may be suited to produce a tissue path that curves around the arcus tendineus, e.g., to exit the pelvic region by passing through the obturator internus above the arcus tendineus, pass behind the arcus tendineus, and re-enter the pelvic region by passing through the levator ani at a location below the arcus tendineus. The curved dilator may be considered to be a two-dimensional form, in that it the curvature of the dilator can define a two-dimensional plane.
  • As exemplary dimensions, a curved dilator may include a curved portion that has a radius of curvature in the range from 0.5 to 1.5 centimeters and a length (measured as the arclength of the curved portion) of from 3 to 5 centimeters. Also optionally, a curved shape or radius of a curved dilator can approximate or match a curved shape or radius of an insertion tool (e.g., a curved distal portion of an insertion tool such as a curved distal needle), and the curves of both a dilator and a curved distal portion of an insertion tool (e.g., needle) may be shaped to mach a tissue path that exits the pelvic area at a location near the ischial spine and above the arcus tendineus by passing through the obturator internus muscle, continues around the areus tendineus, and re-enters the pelvic region below the arcus tendineus by passing through the levator ani muscle. Thus, according to certain specific embodiments of the use of a curved dilator, a curved dilator may be used with a curved needle (or other insertion tool) designed to fit within an internal space at a hollow interior of the dilator, with the curved insertion tool and the curved dilator having a size and shape to define a tissue path passing around the arcus tendineus as described.
  • Further design features can relate to dilators and insertion tools that include anti-rotation or alignment features, in particular with the use of a curved needle insertion tool and a curved dilator. An anti-rotation or alignment feature may be in the form of opposing and coordinated structural features of the dilator and a tip of an insertion tool (e.g., needle) that together can: interconnect the dilator and tip of insertion tool to produce a desired alignment; prevent relative movement of the two pieces such as to prevent rotation of the dilator relative to the tool; or both. The alignment feature causes the dilator to be placed on the needle in a specific alignment, which if the needle and dilator are both curved as discussed above, causes the curve of the needle to be aligned with the curve of the dilator. An example of an alignment and anti-rotation feature is a keyed structure, as will be understood, that includes one or more inter-connecting surfaces and structures between the dilator and the needle to allow the dilator to removably connect to the needle when the two are properly aligned, and then to also prevent rotation between the two when the two are connected. Other mechanical structures will also allow the dilator to be attached at an end of a needle in a manner to produce a desired alignment and to prevent rotation of the dilator relative to the needle.
  • An example of an implant having a curved. (two dimensional) dilator adapted to removably engage a three dimensional insertion tool that includes a curved (two dimensionally curved) distal end, is illustrated at FIG. 4. FIG. 4 schematically illustrates a prolapse support device (i.e., implant) 110 for treating vaginal prolapse, and insertion tool 122. Implant 110 includes end (i.e., “extension”) portions 114 and 116 connected to central support portion 120. Sutures (optional) 118 extend along the lengths of each of extensions 114 and 116 and are connected to central support portion 118 and extensions 114 and 116. Rigid, curved dilators (in two dimensions) 112 are attached at each distal end of extension portions 114 and 116.
  • Still referring to FIG. 4, insertion tool 122 (not to scale) includes handle 124, shaft 126, and curved distal portion or “needle” 128. (Needle 128 includes a two-dimensional semi-circular form, and needle 128 along with shaft 126 together are in three dimensions.) Needle 128 is designed to engage dilators 112 by fitting inside of a dilator 112, e.g., inside of internal space 113 of each dilator, so that needle 128, by use of handle 124 of tool 122, can be used to push dilator 112 through tissue by rotating handle 124; rotation of handle 124 about axis 121, defined by handle 124 and shaft 126, rotates curved needle 128. Curved needle 128, shaft 126, and handle 124 are in three dimensions. Curved needle 128 is substantially a partial circle (e.g., half circle) that rotates to define a curved tissue path when handle 124 is rotated about longitudinal axis 121. Not shown is an optional protective flexible cover or sheaths that could extend over and contain extension portions 114 and 116.
  • FIG. 4A shows an end view of tool 122, illustrating the half-circle shape of curved end 128, in view of handle 124. Curved end 128 includes an arclength of approximately 180 degrees, starting at a trailing end 129 that connects to shaft 126, and extending to needle tip 127. FIG. 4B illustrates these features of tool 122 when connected to dilator 112, which is also attached to extension portion 116 of implant 110.
  • According to other embodiments of implants, distal ends of extension portions can be attached or engaged with an insertion tool in the form of a needle or in the form a tool comprising a distal curved portion (e.g., needle) with attached shaft and handle, the former needle being capable of being manipulated using a separate tool such as a needle-driver, forceps, or surgical pliers, the latter type of needle being capable of being manipulated using the handle, which will be external to the patient during a transvaginal surgical procedure. Thus, exemplary insertion tools include a small two-dimensional needle that can be manipulated during a transvaginal installation by another surgical tool; a tool having a distal portion comprising a curved needle (including a needle tip), shaft, and handle, that can be used directly to install the implant; a dilator; or another type of tool that can be used to allow ends of an extension portion of an implant to be transvaginally installed in tissue as desired.
  • A specific example of an attached insertion tool can be a small needle that can be securely attached at distal end of an extension portion of an implant. The needle can be straight or curved (e.g., in two dimensions), and may preferably be sized to be manipulated using a standard surgical grasping instrument such as a pliers, forceps, or needle-passer, and can be can be shaped and sized as desired, such as with a curve and length that facilitate passing the needle through a tissue path that wraps around an arcus tendineus. For example, pre-attached small, two-dimensional curved needle may include a curved portion that has a radius of curvature in the range from 0.5 to 1.5 centimeters and a length (measured as the arclength of the curved portion) of from 3 to 5 centimeters. A distal end of an extension portion of an implant may be attached at a trailing end of the needle. (Attachment at trailing end of a needle or at a leading end of a needle refers to attachment that is within a distance of an end of a needle of 25 percent of the total needle length.) The attached insertion tool (e.g., needle) can optionally include useful features that allow manipulation and placement of the needle as desired to place the implant in a useful position. For example, a needle may include flat portions that allow easy grasping and manipulation with a standard needle-driver, forceps, or pliers. The needle may be plastic or metal. The curve and sizing of the needle can be shaped to match a tissue path that exits the pelvic area at a region of the arcus tendineus, wraps around an arcus tendineus, and re-enters the pelvic region.
  • FIG. 5 schematically illustrates a prolapse support device for treating vaginal prolapse, the device including attached insertion tools in the form of small curved two-dimensional needles having length L and radius of curvature R. Implant 130 includes end portions 134 and 136 connected to central support portion 140. Sutures 138 extend along the lengths of each of extensions 134 and 136 and are connected to central support portion 140 and extensions 134 and 136. Attached insertion tools 132, in the form of small curved two-dimensional needles, are attached to distal ends of extensions 134 and 136. Length L (the arclength of each needle) can be as desired, e.g., from 3 to 5 centimeters. Curvature of radius R can be as desired, e.g., from 0.5 to 1.5 centimeters. Insertion tools 132 are designed to be transvaginally manipulated by a tool such as a needle driver, surgical pliers, surgical forceps, etc., during installation of implant 130, e.g., according to methods described herein.
  • FIG. 6 schematically illustrates a prolapse support device that includes an implant having two pre-attached insertion tools. Implant 142 includes end portions 144 and 148 connected to central support portion 150. Sutures 146 extend along the lengths of each of extension 144 and 148 and are connected to central support portion 150 and extensions 144 and 148. Insertion tools 152 include shaft 156, handle 154, and curved distal portion, needles 158, each needle being attached at a distal end of extension portions 144 and 148.
  • Each tool 152 includes handle 154, shaft 152, curved needle end 158 at a distal end of shaft 152, and needle tip 160. Tips 160 are leading edges of curved needles 158, and each is attached to a distal end of an extension portion 144 or 148. With this design, a surgeon receives the implant product 142 with tools 152 attached; the surgeon installs implant 142, transvaginally, with support portion 150 being attached to vaginal tissue. The surgeon uses each of tools 152 to place ends of extension portions 146 and 148 bilaterally through tissue in the region of the arcus tendineus, e.g., near the ischial spine. Curved distal end 158 of each tool 152 allows the surgeon to lead a distal end of each extension portion 144 and 148 around the outside of the arcus tendineus and back into the pelvic region at a location below the arcus tendineus, e.g., through the iliococcygeous muscle. This placement can be performed by movement or each tool 152, the movement including rotation of handle 154 about an axis that includes shaft 156, to rotate curved distal end 158, also about the axis of shaft 156. This can pass tip 160 and a distal end of an extension portion around an arcus tendineus, with the distal end exiting and re-entering the pelvic region. The surgeon can then disconnect the end of each extension portion from each tip 160 by cutting the extension portions 144 and 148 near tip 160 of each tool 152. After cutting the end of each extension portion 144 and 148, the needle and tool can be removed from the pelvic region and each extension portion 144 and 148 can be manipulated to adjust and position the extension portion and implant 142 as desired to support vaginal tissue connected to support portion 150. This can optionally include producing another tissue path to an external location and leading the end of each extension portion 144 and 148 through that tissue path to the external location in the perirectal region such as is illustrated in FIGS. 7 and 9. Or, each extension portion 144 and 148 can be severed and severed ends can be left at locations within the pelvic floor region without leading extension portions 144 and 148 to an external incision.
  • According to particular embodiments, a kit according to the invention can include an implant and a tool or multiple tools for installation, e.g., with the insertion tool being either removably enjoyable or attached (e.g., permanently) at a distal end of an extension portion of the implant. Referring to FIG. 10, a kit is illustrated (not to scale) to include a mesh tape implant (220) for supporting vaginal tissue, insertion tool 200 comprising a distal end having a curved needle, and tunneler device 230. FIG. 4 includes an illustration of an exemplary insertion tool useful for installing a mesh to pass above the arcus tendineus. Tool 200 (Deschamps Needle) of FIG. 10 is shown as a side view. Tunneler device 230 (e.g., IVS tunneler) includes hollow trocar 232 and flexible plastic plug 234, as are known. Tool 200 includes handle 202, shaft 204 having a proximal end connected to handle 202, shaft 204 connected at a distal end to curved end (e.g., “needle”) 208. The diameter of the curved needle portion 208 is shown to be 1 inch, meaning that the radius of curvature is about 0.5 inch; other sizes of the curve may also be useful. Curved end 208 defines a two-dimensional curve, and the combination of curved end 208 with shaft 204 together are in three dimensions.
  • Still referring to FIG. 10, tip 210 of curved end 208 can be adapted to allow an end of a mesh implant to be held (removably engaged) by tip 210. Tip 210 can also be sharpened to allow the tip to be passed through tissue. Tool 200 may be a Deschamps Needle or similar structure having a handle, shaft, and a curved portion at the end of the shaft. A distal end (222) of mesh implant 220 can be attached to the end. (tip) of curved portion of curved needle 208 of tool 200. During use, a surgeon can make a vaginal incision to allow transvaginal insertion of curved end 208 of tool 200, with a distal end 222 of implant 220 attached at the end (tip) 210 of curved portion 208. Center portion 224 of implant 220 is attached to the vaginal apex to provide support, and each/of ends 222 can be extended bi-laterally through tissue paths that pass through a region of the arcus tendineus, such as through the obturator internus muscle just above the arcus tendineus at the level of the ischial spine. Tunneler device 230 can be used to separately retrieve each of ends 222 of mesh implant 220 and draw ends 222 through a tissue path to an external incision, e.g., an external incision in the perirectal region.
  • The invention contemplates placement of an implant, as described, to treat a condition of vaginal tissue prolapse, by use of transvaginal surgical methods. The present description identifies certain combinations of implants, tools, and procedures, but as will be understood based on the present description, many different variations on the present methods, tools, and procedures will be useful, as will combination of implant, tool, and procedure.
  • According to one embodiment of the invention, using a curved Deschamps or similar needle, an extension portion of an implant can be inserted trough a vaginal incision and a central portion of the implant can be attached to vaginal tissue that is to be supported. Two opposing tissue paths are created from the vaginal tissue to regions of the arcus tendineus, e.g., above the arcus tendineus at a level of the ischial spine, one on each side of the pelvic region. Each end (“extension”) portion of the implant can then be extended through a tissue path and above or below the arcus tendineus, such as through the obturator internus muscle or iliococcygeus, optionally also as close to the ischial spine as possible, using the curved needle. The end portion of the implant is passed around the outside of the white line and passed back into the pelvic region either below or above the white line, either through obturator internus or the iliococcygeus muscle. This location of the mesh end is illustrated in FIGS. 7, 7A, 8, 9, and 9A. The end of the mesh thus passes back into the pelvic floor and can be subsequently passed through a tissue passage that is created below that pelvic floor location, to an incision made external to the rectal region at each buttock (e.g., 2 to 3 centimeters lateral and 2 to 3 centimeters posterior to the anus).
  • Methods of the invention can involve placement of an implant and extension portion using a system as shown in FIG. 4. Distal curved portion 128 of tool 122 is engaged with interior space 113 of dilator 112, and tool 122 can be inserted transvaginally and rotated to produce a tissue path in a region of the arcus tendineus. Tool 122 then engages the second dilator to make a second opposite tissue path, transvaginally. Each extension portion can be adjusted as desired, and tissue support portion 120 can be attached to vaginal tissue and adjusted. In alternate embodiments that also use tool 122 and implant 110, a tissue path can be produced transvaginally using tool 122, as a first step, then dilator 112 can be engaged with distal end 128 after formation of the tissue path. After engaging dilator 112 and distal end 128, tool 122 can be counter-rotated to cause the dilator to be pulled back through the tissue path. The extension portion and tissue support portion 120 can then be adjusted.
  • Methods of the invention include variations that advantageously do not require any external incision such as two incisions perirectal incisions. Again entering the pelvic region transvaginally, e.g., using a curved Deschamps Needle (or alternately a small curved needle as shown in FIG. 5), an extension portion of an implant can be inserted through a vaginal incision and a central portion of the implant attached to vaginal tissue that is to be supported. Opposing tissue paths are created starting at the vaginal tissue and extending to opposite locations at regions of the arcus tendineus, e.g., above the arcus tendineus at the level of the ischial spine. Each end portion of the implant can then be extended through one of the opposing tissue paths and through obturator internus muscle, as close to the ischial spine as possible. The end portion of the implant is passed (wrapped) around the outside of the white line and passed back into the pelvic region below the white line, through the iliococcygeus muscle. The end of the mesh thus passes back into the pelvic floor. Instead of passing the end portion through a tissue passage that is created between that pelvic floor location and an external incision (e.g., in the rectal region at each buttocks), however, the end portion can be cut off, e.g., within the pelvic region, and the severed end left in that internal position of the anatomy. The end portion may optionally be secured using a suture. The severed end portions of the implant will remain in place within the defined tissue path and will the implant will support the vaginal tissue.
  • FIG. 7 illustrates an installed mesh tape implant 220 (e.g., as shown in FIG. 10) that includes a central support portion (224) secured to tissue of the vaginal apex, Each of two distal ends 222 of extension portions 221 of implant 220 extends bilaterally to pass above each arcus tendineus (6), near each ischial spine (8). Each of the two distal ends 222 of extension portions 221 of implant 220 then passes thorough the iliococcygeus muscle (not shown), below the white line (6), back to the pelvic floor region and then through two tissue paths, each path extending to an external incision (70) in the perirectal region.
  • FIG. 7A illustrates an alternate embodiment of an installed mesh tape implant 220 (e.g., as shown in FIG. 10) that includes a central support portion 224 secured to tissue of the vaginal apex. Each of two extension portions 221 of implant 220 extends bilaterally to pass above each arcus tendineus (6) near each ischial spine (8). Each of the two extension portions 221 of implant 220 then passes thorough the iliococcygeus muscle (not shown) below the white line (6) and back to the pelvic floor region. Each of the two extension portions 221 of implant 220 is severed to create an end of the extension portion located within the pelvic floor and extension portions 221 are not extended through tissue paths to any external incision.
  • FIG. 8 illustrates another view of an installed mesh tape implant, such as implant 220 shown in FIG. 10. FIG. 8 looks in a direction down into the pelvic cavity, such as from a position in the abdomen. For reference are shown pubic bone 80, bladder 82, obturator internus muscle 84, and iliococcygeous muscle 86. In FIG. 8, a central support portion 224 of a mesh implant 220 is secured using sutures (not shown) to tissue of the apex of vagina 2. Each of the two distal ends 222 of extension portions 221 of implant 220 are extended bilaterally and passed through opposing tissue paths above each arcus tendineus (6), near each ischial spine (8), e.g., through obturator internus muscle 84. The far portions and distal ends 222 of the extension portions 221 of implant 220 are not shown in FIG. 8. These far portions of extension portions 221 may extend through alternate tissue paths, such as back into the pelvic region by passing through iliococcygeous muscle 86 at a location below arcus tendineus 6, then either severed at a location within the pelvic floor region or passed to an external incision.
  • FIG. 9 illustrates still another view of an exemplary installed mesh tape implant 220 that includes central support portion 224 secured to tissue of the vaginal apex. FIG. 9 is a view from exterior of the patient, facing the vagina and anus (90). Each of two distal ends 221 of the implant 220 extends bilaterally to pass above each arcus tendineus 6 near each ischial spine 8, around the arcus tendineus 6, and then thorough the iliococcygeus muscle (not shown) below the white line 6 and back to the pelvic floor region. From there each extension portion 221 passes through a tissue path extending to an external incision (70) in the perirectal region.
  • FIG. 9A illustrates an alternate embodiment of an installed mesh tape implant that includes a central support portion 224 secured to tissue of the vaginal apex. FIG. 9 is a view from exterior of the patient, facing the vagina and anus (90). Each of two extension portions 221 of implant 220 extends bilaterally to pass above each arcus tendineus 6 near each ischial spine 8. Each of the two extension portions 221 of the implant 220 then passes around arcus tendineus 6 and then through the iliococcygeus muscle (not shown) below the white line 6 back to the pelvic floor region. Each of the two ends of the implant is severed to create an end that remains internally within the pelvic floor, and the end portions are not extended through tissue paths to external incisions in the perirectal region.

Claims (18)

1-20. (canceled)
21. An insertion tool for placing a pelvic implant, the insertion tool comprising:
a longitudinally extending shaft having a longitudinal axis,
a handle having a proximal end and a distal end, the distal end attached to a proximal end of the shaft, and
a curved portion at a distal end of the shaft, the curved portion being sized and shaped to be used in a transvaginal procedure to define a tissue path that exits the pelvic floor region in a region of the arcus tendineus, partially extends around an arcus tendineus, and re-enters the pelvic floor, wherein the region of the arcus tendineus comprises a region from 2 centimeters above the arcus tendineus to 2 centimeters below the arcus tendineus and between the ischial spine and a distance 3 centimeters anterior to the ischial spine.
22. The insertion tool of claim 21, wherein the curved portion comprises a radius of curvature in the range of from 0.5 to 1.5 centimeters.
23. The insertion tool of claim 21, wherein the curved portion has a length of from 3 to 5 centimeters.
24. The insertion tool of claim 21, wherein the curved portion is substantially a shape of a partial circle of from 90 to 270 degrees.
25. The insertion tool of claim 21, wherein the curved portion is substantially a shape of a partial circle of from 170 to 190 degrees.
26. The insertion tool of claim 21, wherein the shaft is substantially straight.
27. The insertion tool of claim 21, wherein the longitudinal axis of the shaft is aligned with a longitudinal axis of the handle.
28. The insertion tool of claim 21, wherein the curved distal end is capable of engaging a dilator and pushing the dilator through tissue.
28. The insertion tool of claim 28, wherein the engagement between the curved distal end and dilator is a permanent attachment or a removable engagement.
30. The insertion tool of claim 21, comprising a second insertion tool, the second insertion tool comprising:
a longitudinally extending shaft having a longitudinal axis,
a handle having a proximal end and a distal end, the distal end attached to a proximal end of the shaft, and
a curved portion at a distal end of the shaft, the being sized and shaped to be used in a transvaginal procedure to define a tissue path that exits the pelvic floor region in a region of the arcus tendineus, partially extends around an arcus tendineus, and re-enters the pelvic floor, wherein the region of the arcus tendineus comprises a region from 2 centimeters above the arcus tendineus to 2 centimeters below the arcus tendineus and between the ischial spine and a distance 3 centimeters anterior to the ischial spine.
31. The insertion tool of claim 28 wherein a distal end of the curved portion comprises an anti-rotation feature that prevents relative movement between the curved portion and the dilator.
32. The insertion tool of claim 28 wherein a distal end of the curved portion comprises an alignment feature that engages the dilator in a desired alignment.
33. An insertion tool for placing a pelvic implant, the insertion tool comprising a longitudinal extending shaft having a longitudinal axis,
a handle having a proximal end and a distal end, the distal end attached to a proximal end of the shaft, and
a curved portion at a distal end of the shaft, the curved portion having a three-dimensional shape and being sized and shaped to be used in a transvaginal procedure to define a tissue path in a region of the arcus tendinous at the level of the ischial spine, and wherein the curved portion extends from the longitudinal axis and extends in two additional directions.
34. The insertion tool of claim 21, wherein the curved portion comprises a radius of curvature in the range of from 0.5 to 1.5 centimeters.
36. The insertion tool of claim 21, wherein the curved portion has a length of from 3 to 5 centimeters.
37. The insertion tool of claim 21, wherein the curved portion is substantially a shape of a partial circle of from 90 to 270 degrees.
38. The insertion tool of claim 21, wherein the curved portion is substantially a shape of a partial circle of from 170 to 190 degrees.
US15/065,362 2005-07-26 2016-03-09 Methods and systems for treatment of prolapse Abandoned US20160184070A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/065,362 US20160184070A1 (en) 2005-07-26 2016-03-09 Methods and systems for treatment of prolapse

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US70270505P 2005-07-26 2005-07-26
US70270405P 2005-07-26 2005-07-26
US70270005P 2005-07-26 2005-07-26
PCT/US2006/028828 WO2007016083A1 (en) 2005-07-26 2006-07-25 Methods and systems for treatment of prolapse
US11/989,256 US8535217B2 (en) 2005-07-26 2006-07-25 Methods and systems for treatment of prolapse
US14/025,988 US9060839B2 (en) 2005-07-26 2013-09-13 Methods and systems for treatment of prolapse
US14/743,259 US9283064B2 (en) 2005-07-26 2015-06-18 Methods and systems for treatment of prolapse
US15/065,362 US20160184070A1 (en) 2005-07-26 2016-03-09 Methods and systems for treatment of prolapse

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14/743,259 Continuation US9283064B2 (en) 2005-07-26 2015-06-18 Methods and systems for treatment of prolapse

Publications (1)

Publication Number Publication Date
US20160184070A1 true US20160184070A1 (en) 2016-06-30

Family

ID=37339115

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/989,256 Active 2029-12-16 US8535217B2 (en) 2005-07-26 2006-07-25 Methods and systems for treatment of prolapse
US14/025,988 Active US9060839B2 (en) 2005-07-26 2013-09-13 Methods and systems for treatment of prolapse
US14/743,259 Active US9283064B2 (en) 2005-07-26 2015-06-18 Methods and systems for treatment of prolapse
US15/065,362 Abandoned US20160184070A1 (en) 2005-07-26 2016-03-09 Methods and systems for treatment of prolapse

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US11/989,256 Active 2029-12-16 US8535217B2 (en) 2005-07-26 2006-07-25 Methods and systems for treatment of prolapse
US14/025,988 Active US9060839B2 (en) 2005-07-26 2013-09-13 Methods and systems for treatment of prolapse
US14/743,259 Active US9283064B2 (en) 2005-07-26 2015-06-18 Methods and systems for treatment of prolapse

Country Status (6)

Country Link
US (4) US8535217B2 (en)
EP (1) EP1912590A1 (en)
AU (1) AU2006275977B2 (en)
BR (1) BRPI0613896A2 (en)
CA (1) CA2615130A1 (en)
WO (1) WO2007016083A1 (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0609970A2 (en) 2005-04-05 2011-10-11 Ams Res Corp pelvic implant, surgical instrument and combination
US8109866B2 (en) 2005-04-26 2012-02-07 Ams Research Corporation Method and apparatus for prolapse repair
US8864650B2 (en) 2005-06-21 2014-10-21 Ams Research Corporation Methods and apparatus for securing a urethral sling to a pubic bone
WO2007002071A1 (en) 2005-06-21 2007-01-04 Ams Research Corporation Apparatus for securing a urethral sling to pubic bone
WO2007016083A1 (en) 2005-07-26 2007-02-08 Ams Research Corporation Methods and systems for treatment of prolapse
AU2007217930B2 (en) 2006-02-16 2012-10-18 Boston Scientific Scimed, Inc. Surgical articles and methods for treating pelvic conditions
WO2007137226A2 (en) 2006-05-19 2007-11-29 Ams Research Corporation Method and articles for treatment of stress urinary incontinence
JP4971440B2 (en) 2006-06-16 2012-07-11 エーエムエス リサーチ コーポレイション Surgical implants, tools, and methods for treating pelvic disease
AU2007261254B2 (en) 2006-06-22 2013-12-12 Boston Scientific Scimed, Inc. Adjustable tension incontinence sling assemblies
CA2653253C (en) 2006-07-25 2014-03-18 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
US8388514B2 (en) 2006-10-26 2013-03-05 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
CA2667193C (en) 2006-10-26 2016-02-16 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
US8951185B2 (en) 2007-10-26 2015-02-10 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
WO2008058163A2 (en) 2006-11-06 2008-05-15 Caldera Medical, Inc. Implants and procedures for treatment of pelvic floor disorders
AU2008271061B2 (en) 2007-06-29 2013-11-14 Boston Scientific Scimed, Inc. Surgical articles and methods for treating pelvic conditions
US20090018387A1 (en) * 2007-07-10 2009-01-15 Veronikis Dionysios K Repair of Vaginal Prolapse
US20100217070A1 (en) * 2007-07-16 2010-08-26 Steven Neil Peterson Surgical devices and methods for treating pelvic conditions
CA2693198C (en) 2007-07-27 2014-10-14 Ams Research Corporation Pelvic floor treatments and related tools and implants
CA2698558C (en) 2007-09-21 2015-11-17 Ams Research Corporation Pelvic floor treatments and related tools and implants
US20090240102A1 (en) 2008-03-14 2009-09-24 Ajay Rane Apparatus and method for repairing vaginal reconstruction
WO2009145911A1 (en) 2008-05-29 2009-12-03 Ams Research Corporation Minimally invasive levator avulsion repair
US8727963B2 (en) 2008-07-31 2014-05-20 Ams Research Corporation Methods and implants for treating urinary incontinence
JP2012500712A (en) 2008-08-25 2012-01-12 エーエムエス リサーチ コーポレイション Implants and methods with minimal invasion
US9017243B2 (en) 2008-08-25 2015-04-28 Ams Research Corporation Minimally invasive implant and method
IL210584A0 (en) * 2011-01-12 2011-03-31 Ilana Neuman An implant for supporting the pelvic floor
US8944990B2 (en) 2008-10-27 2015-02-03 Ams Research Corporation Surgical needle and anchor system with retractable features
CA2747608A1 (en) * 2009-01-05 2010-07-08 Caldera Medical, Inc. Implants and procedures for supporting anatomical structures
CA2748894C (en) 2009-02-10 2018-11-13 Ams Research Corporation Surgical articles and methods for treating urinary incontinence
WO2010105168A1 (en) 2009-03-12 2010-09-16 Beyer Roger D Method and apparatus for prolapse repair
US8414468B2 (en) * 2009-08-18 2013-04-09 Eric Sokol Anal sling system and method to treat fecal incontinence
BR112012008679B1 (en) 2009-10-13 2022-01-25 Materna Medical, Inc Vaginal dilatation device, and, methods for dilating a vagina during labor pains and for preventing tissue damage during childbirth
WO2011079222A2 (en) * 2009-12-23 2011-06-30 Boston Scientific Scimed, Inc. Less traumatic method of delivery of mesh-based devices into human body
WO2011082220A1 (en) 2009-12-30 2011-07-07 Ams Research Corporation Elongate implant system and method for treating pelvic conditions
WO2011082287A1 (en) 2009-12-30 2011-07-07 Ams Research Corporation Implant systems with tensioning feedback
WO2011082330A1 (en) 2009-12-30 2011-07-07 Ams Research Corporation Implantable sling systems and methods
AU2011218197B2 (en) 2010-02-16 2015-05-21 Boston Scientific Scimed, Inc. Bioabsorbable mesh for surgical implants
CA2789786C (en) 2010-02-23 2019-04-16 Ams Research Corporation Surgical articles and methods
US9445881B2 (en) 2010-02-23 2016-09-20 Boston Scientific Scimed, Inc. Surgical articles and methods
US10028813B2 (en) 2010-07-22 2018-07-24 Boston Scientific Scimed, Inc. Coated pelvic implant device and method
US9968428B2 (en) 2010-12-16 2018-05-15 Boston Scientific Scimed, Inc. Surgical tools, systems, and related implants and methods
US9572648B2 (en) 2010-12-21 2017-02-21 Justin M. Crank Implantable slings and anchor systems
CN202036367U (en) * 2011-01-17 2011-11-16 王江宁 Artificial muscle prosthesis implanted into human body and capable of elastically fixing joint
US9125717B2 (en) 2011-02-23 2015-09-08 Ams Research Corporation Implant tension adjustment system and method
AU2012238105B2 (en) 2011-03-28 2017-04-06 Boston Scientific Scimed, Inc. Implants, tools, and methods for treatments of pelvic conditions
US8808162B2 (en) 2011-03-28 2014-08-19 Ams Research Corporation Implants, tools, and methods for treatment of pelvic conditions
US20120253108A1 (en) 2011-03-28 2012-10-04 Fischer Brian G Implants, tools, and methods for treatment of pelvic conditions
AU2012236180B2 (en) 2011-03-30 2016-01-14 Boston Scientific Scimed, Inc. Implants, tools, and methods for treatment of pelvic conditions
US9492259B2 (en) 2011-03-30 2016-11-15 Astora Women's Health, Llc Expandable implant system
US9943392B2 (en) 2011-05-04 2018-04-17 Boston Scientific Scimed, Inc. Implants, tools, and methods for treatment of pelvic conditions
WO2012151543A1 (en) 2011-05-05 2012-11-08 Ams Research Corporation Tools and methods for treatment of pelvic conditions
US10058240B2 (en) 2011-06-29 2018-08-28 Boston Scientific Scimed, Inc. Systems, implants, tools, and methods for treatments of pelvic conditions
US20130006049A1 (en) 2011-06-30 2013-01-03 Alexander James A Implants, tools, and methods for treatments of pelvic conditions
US10667895B2 (en) 2011-06-30 2020-06-02 Boston Scientific Scimed, Inc. Implants, tools, and methods for treatments of pelvic conditions
US9351723B2 (en) 2011-06-30 2016-05-31 Astora Women's Health, Llc Implants, tools, and methods for treatments of pelvic conditions
AU2012282736B2 (en) 2011-07-11 2017-02-02 Boston Scientific Scimed, Inc. Implants, tools, and methods for treatments of pelvic conditions
US9414903B2 (en) 2011-07-22 2016-08-16 Astora Women's Health, Llc Pelvic implant system and method
EP2734148B1 (en) 2011-07-22 2019-06-05 Boston Scientific Scimed, Inc. Pelvic implant system
WO2013020076A1 (en) 2011-08-03 2013-02-07 Ams Research Corporation Systems, methods, and implants for treating prolapse or incontinence
US9492191B2 (en) 2011-08-04 2016-11-15 Astora Women's Health, Llc Tools and methods for treatment of pelvic conditions
US20130035555A1 (en) 2011-08-05 2013-02-07 Alexander James A Systems, implants, tools, and methods for treatment of pelvic conditions
US10098721B2 (en) 2011-09-01 2018-10-16 Boston Scientific Scimed, Inc. Pelvic implant needle system and method
USD736382S1 (en) 2011-09-08 2015-08-11 Ams Research Corporation Surgical indicator with backers
USD721175S1 (en) 2011-09-08 2015-01-13 Ams Research Corporation Backers for surgical indicators
USD721807S1 (en) 2011-09-08 2015-01-27 Ams Research Corporation Surgical indicators
US10265152B2 (en) 2011-10-13 2019-04-23 Boston Scientific Scimed, Inc. Pelvic implant sizing systems and methods
US9192458B2 (en) 2012-02-09 2015-11-24 Ams Research Corporation Implants, tools, and methods for treatments of pelvic conditions
WO2013126130A1 (en) * 2012-02-23 2013-08-29 Northwestern University Improved suture
EP2903559A4 (en) 2012-10-01 2016-04-13 Ams Res Corp Conductive and degradable implant for pelvic tissue treatment
CA2959788C (en) 2014-09-04 2022-04-19 Duke University Implantable mesh and method of use
WO2017011389A1 (en) 2015-07-10 2017-01-19 Materna Medical, Inc. Systems and methods for the treatment and prevention of female pelvic dysfunction
CN108524059A (en) * 2018-05-03 2018-09-14 上海市第妇婴保健院 The sling operation method and device of ligamentum inguinale treats pelvic organ prolapse in front of ligamentum teres to anterior superior spine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099258A1 (en) * 2001-01-23 2002-07-25 Staskin David R. Sling delivery system and method of use

Family Cites Families (390)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124136A (en) * 1964-03-10 Method of repairing body tissue
US642080A (en) * 1899-05-15 1900-01-30 Franklin Burnam Animal-exterminator.
US1111111A (en) 1914-04-15 1914-09-22 George R Warner Holdback.
US2738790A (en) * 1954-08-12 1956-03-20 George P Pilling & Son Company Suturing instrument
US3182662A (en) 1962-07-25 1965-05-11 Vithal N Shirodkar Plastic prosthesis useful in gynaecological surgery
US3384073A (en) 1964-04-21 1968-05-21 Ethicon Inc Surgical device for correction of urinary incontinence
US3311110A (en) * 1964-07-15 1967-03-28 American Cyanamid Co Flexible composite suture having a tandem linkage
US3472232A (en) 1967-05-31 1969-10-14 Abbott Lab Catheter insertion device
US3580313A (en) 1969-01-07 1971-05-25 Mcknight Charles A Surgical instrument
US3816576A (en) 1971-02-08 1974-06-11 F Auzel Preparing fluorescent materials for optical frequency conversion
US3763860A (en) 1971-08-26 1973-10-09 H Clarke Laparoscopy instruments and method for suturing and ligation
US3788303A (en) * 1972-01-24 1974-01-29 American Cystoscope Makers Inc Orthogonally deflectable endoscope
US3789828A (en) * 1972-09-01 1974-02-05 Heyer Schulte Corp Urethral prosthesis
US3858783A (en) * 1972-11-20 1975-01-07 Nikolai Nikolaevich Kapitanov Surgical instrument for stitching up tissues with lengths of suture wire
US3815576A (en) 1973-01-26 1974-06-11 D Balaban Artificial sphincter
DE2305815A1 (en) 1973-02-07 1974-08-08 Kurt Seuberth DEVICE FOR SEPARATING SURGICAL FEEDS
US3924633A (en) 1974-01-31 1975-12-09 Cook Inc Apparatus and method for suprapubic catheterization
US3934201A (en) * 1974-03-22 1976-01-20 Majefski Richard L Low power consumption stereo transmitter and receiver system
US4037603A (en) 1975-05-13 1977-07-26 Wendorff Erwin R Metallic surgical suture
US3995619A (en) 1975-10-14 1976-12-07 Glatzer Stephen G Combination subcutaneous suture remover, biopsy sampler and syringe
US4019499A (en) 1976-04-22 1977-04-26 Heyer-Schulte Corporation Compression implant for urinary incontinence
US4128100A (en) 1976-10-08 1978-12-05 Wendorff Erwin R Suture
US5633286B1 (en) 1977-03-17 2000-10-10 Applied Elastomerics Inc Gelatinous elastomer articles
US4172458A (en) 1977-11-07 1979-10-30 Pereyra Armand J Surgical ligature carrier
US4235238A (en) 1978-05-11 1980-11-25 Olympus Optical Co., Ltd. Apparatus for suturing coeliac tissues
US4246660A (en) * 1978-12-26 1981-01-27 Queen's University At Kingston Artificial ligament
US4367998A (en) * 1979-09-13 1983-01-11 United Kingdom Atomic Energy Authority Manipulators
US4636138A (en) * 1982-02-05 1987-01-13 American Robot Corporation Industrial robot
US4500065A (en) * 1982-03-01 1985-02-19 Cincinnati Milacron Inc. Releasable tool mount for manipulator
SU1342486A1 (en) 1982-06-29 1987-10-07 М.А. Мороз Needle holder
US4441497A (en) 1982-10-21 1984-04-10 Paudler Franklin T Universal suture passer
US4509516A (en) 1983-02-24 1985-04-09 Stryker Corporation Ligament tunneling instrument
US4548202A (en) 1983-06-20 1985-10-22 Ethicon, Inc. Mesh tissue fasteners
US4873976A (en) 1984-02-28 1989-10-17 Schreiber Saul N Surgical fasteners and method
US4651201A (en) * 1984-06-01 1987-03-17 Arnold Schoolman Stereoscopic endoscope arrangement
SU1225547A1 (en) 1984-08-03 1986-04-23 Московский Городской Ордена Ленина И Ордена Трудового Красного Знамени Научно-Исследовательский Институт Скорой Помощи Им.Н.В.Склифосовского Surgical instrument
US4865031A (en) 1985-07-12 1989-09-12 Keeffe Paul J O Fabric and method of use for treatment of scars
US4632100A (en) 1985-08-29 1986-12-30 Marlowe E. Goble Suture anchor assembly
GB8525565D0 (en) 1985-10-17 1985-11-20 Speedhom B B Surgical replacement of ligaments
US4722056A (en) * 1986-02-18 1988-01-26 Trustees Of Dartmouth College Reference display systems for superimposing a tomagraphic image onto the focal plane of an operating microscope
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
GB8611129D0 (en) 1986-05-07 1986-06-11 Annis D Prosthetic materials
US5078140A (en) * 1986-05-08 1992-01-07 Kwoh Yik S Imaging device - aided robotic stereotaxis system
US5386836A (en) * 1986-10-14 1995-02-07 Zedlani Pty Limited Urinary incontinence device
ES2030732T3 (en) 1986-10-14 1992-11-16 Zedlani Pty. Limited DEVICE FOR URINARY INCONTINENCE.
US4809747A (en) * 1987-07-31 1989-03-07 General Motors Corporation Quick disconnect device
US4808898A (en) * 1987-09-30 1989-02-28 Keith Pearson Gripper assembly for robot arm
DE3742053C1 (en) * 1987-12-11 1989-03-16 Wolf Gmbh Richard Holder for medical instruments
CA1331032C (en) * 1988-01-25 1994-07-26 Thony, Franz Apparatus for detachably connecting two parts
US5187796A (en) * 1988-03-29 1993-02-16 Computer Motion, Inc. Three-dimensional vector co-processor having I, J, and K register files and I, J, and K execution units
US4989253A (en) * 1988-04-15 1991-01-29 The Montefiore Hospital Association Of Western Pennsylvania Voice activated microscope
EP0437481B1 (en) 1988-10-04 1995-03-15 PETROS Peter Emmanuel Surgical instrument prosthesis
US5123428A (en) 1988-10-11 1992-06-23 Schwarz Gerald R Laparoscopically implanting bladder control apparatus
US5012822A (en) 1988-10-11 1991-05-07 Schwarz Gerald R Method for controlling urinary incontinence
US5002418A (en) * 1988-12-09 1991-03-26 Vsi Corporation Hold down device with extended capture pawl mechanism
US5007894A (en) 1989-02-10 1991-04-16 Goran Enhorning Female incontinence device
US5013292A (en) 1989-02-24 1991-05-07 R. Laborie Medical Corporation Surgical correction of female urinary stress incontinence and kit therefor
US4938760A (en) 1989-03-29 1990-07-03 American Medical Systems, Inc. Female suspension procedure
US4932962A (en) 1989-05-16 1990-06-12 Inbae Yoon Suture devices particularly useful in endoscopic surgery and methods of suturing
JPH034831A (en) * 1989-06-01 1991-01-10 Toshiba Corp Endoscope device
GB8924806D0 (en) 1989-11-03 1989-12-20 Neoligaments Ltd Prosthectic ligament system
US5013316A (en) 1990-03-26 1991-05-07 Marlowe Goble E Soft tissue anchor system
US5019032A (en) 1990-04-03 1991-05-28 Robertson Jack R Refined suspension procedure with implement for treating female stress incontinence
US5086401A (en) * 1990-05-11 1992-02-04 International Business Machines Corporation Image-directed robotic system for precise robotic surgery including redundant consistency checking
US5256133A (en) 1990-09-05 1993-10-26 Spitz Robert M Device for correcting stress urinary incontinence
US5368595A (en) 1990-09-06 1994-11-29 United States Surgical Corporation Implant assist apparatus
US5053043A (en) 1990-09-28 1991-10-01 Vance Products Incorporated Suture guide and method of placing sutures through a severed duct
US5085661A (en) * 1990-10-29 1992-02-04 Gerald Moss Surgical fastener implantation device
JPH06506366A (en) * 1990-12-06 1994-07-21 ダブリュ.エル.ゴア アンド アソシエーツ,インコーポレイティド Implantable bioabsorbable components
US5149329A (en) 1990-12-12 1992-09-22 Wayne State University Surgical suture carrier and method for urinary bladder neck suspension
US5203864A (en) 1991-04-05 1993-04-20 Phillips Edward H Surgical fastener system
US5269783A (en) 1991-05-13 1993-12-14 United States Surgical Corporation Device and method for repairing torn tissue
US5279309A (en) * 1991-06-13 1994-01-18 International Business Machines Corporation Signaling device and method for monitoring positions in a surgical operation
US5182641A (en) * 1991-06-17 1993-01-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Composite video and graphics display for camera viewing systems in robotics and teleoperation
US5294209A (en) * 1991-07-25 1994-03-15 Yamaha Hatsudoki Kabushiki Kaisha Tool attaching device
US5184601A (en) * 1991-08-05 1993-02-09 Putman John M Endoscope stabilizer
US5141520A (en) 1991-10-29 1992-08-25 Marlowe Goble E Harpoon suture anchor
US5439467A (en) 1991-12-03 1995-08-08 Vesica Medical, Inc. Suture passer
ATE176998T1 (en) 1991-12-03 1999-03-15 Boston Scient Ireland Ltd INSTRUMENT FOR PASSING A SEWING THREAD
WO1993010715A2 (en) 1991-12-03 1993-06-10 Vesitec Medical, Inc. Surgical treatment of stress urinary incontinence
US5935122A (en) 1991-12-13 1999-08-10 Endovascular Technologies, Inc. Dual valve, flexible expandable sheath and method
US5281220A (en) * 1992-01-13 1994-01-25 Blake Joseph W Iii Endoscopic instrument
US5631973A (en) * 1994-05-05 1997-05-20 Sri International Method for telemanipulation with telepresence
CA2090000A1 (en) 1992-02-24 1993-08-25 H. Jonathan Tovey Articulating mesh deployment apparatus
WO1993017635A1 (en) 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
US5620459A (en) * 1992-04-15 1997-04-15 Microsurge, Inc. Surgical instrument
US5403328A (en) 1992-04-22 1995-04-04 United States Surgical Corporation Surgical apparatus and method for suturing body tissue
US5188636A (en) * 1992-05-07 1993-02-23 Ethicon, Inc. Purse string suture instrument
FR2691093B1 (en) * 1992-05-12 1996-06-14 Univ Joseph Fourier ROBOT FOR GUIDANCE OF GESTURES AND CONTROL METHOD.
US5501695A (en) 1992-05-27 1996-03-26 The Anspach Effort, Inc. Fastener for attaching objects to bones
US5284130A (en) * 1992-06-03 1994-02-08 Ratliff Jack L Surgical instrument positioning and securing apparatus
DE4220283C2 (en) 1992-06-20 1994-05-19 Singer Spezialnadelfab Surgical needle-thread combination
IT1265008B1 (en) 1992-07-15 1996-10-17 Lopez Francisco Garcia VAGINAL SELF-SUTURE DEVICE TO AVOID URINARY INCONTINENCE IN WOMEN
US5657429A (en) * 1992-08-10 1997-08-12 Computer Motion, Inc. Automated endoscope system optimal positioning
US6048351A (en) 1992-09-04 2000-04-11 Scimed Life Systems, Inc. Transvaginal suturing system
US5362294A (en) 1992-09-25 1994-11-08 Seitzinger Michael R Sling for positioning internal organ during laparoscopic surgery and method of use
US5281237A (en) * 1992-09-25 1994-01-25 Gimpelson Richard J Surgical stitching device and method of use
US5337736A (en) 1992-09-30 1994-08-16 Reddy Pratap K Method of using a laparoscopic retractor
ES2049653B1 (en) 1992-10-05 1994-12-16 Velazquez Francisco Farrer CORRECTIVE DEVICE FOR FEMALE URINARY INCONTINENCE.
US5383904A (en) * 1992-10-13 1995-01-24 United States Surgical Corporation Stiffened surgical device
US5250033A (en) 1992-10-28 1993-10-05 Interventional Thermodynamics, Inc. Peel-away introducer sheath having proximal fitting
US5397323A (en) * 1992-10-30 1995-03-14 International Business Machines Corporation Remote center-of-motion robot for surgery
US6406480B1 (en) 1992-11-13 2002-06-18 American Med Syst Bone anchor inserter with retractable shield
US5972000A (en) 1992-11-13 1999-10-26 Influence Medical Technologies, Ltd. Non-linear anchor inserter device and bone anchors
IL103737A (en) 1992-11-13 1997-02-18 Technion Res & Dev Foundation Stapler device particularly useful in medical suturing
IL127978A0 (en) 1999-01-08 1999-11-30 Influence Med Tech Ltd Incontinence device
US5328077A (en) 1992-11-19 1994-07-12 Lou Ek Seng Method and apparatus for treating female urinary incontinence
US5400267A (en) * 1992-12-08 1995-03-21 Hemostatix Corporation Local in-device memory feature for electrically powered medical equipment
US5540703A (en) 1993-01-06 1996-07-30 Smith & Nephew Richards Inc. Knotted cable attachment apparatus formed of braided polymeric fibers
AU6236794A (en) 1993-02-22 1994-09-14 Valleylab, Inc. A laparoscopic dissection tension retractor device and method
US5499320A (en) * 1993-03-24 1996-03-12 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Extended task space control for robotic manipulators
WO1994021197A1 (en) 1993-03-25 1994-09-29 C.R. Bard, Inc. Vascular graft
US5474543A (en) 1993-05-17 1995-12-12 Mckay; Hunter A. Single needle apparatus and method for performing retropublic urethropexy
US5520703A (en) 1993-06-07 1996-05-28 Essig; Mitchell N. Laparoscopic deschamp and associated suturing technique
US5370662A (en) 1993-06-23 1994-12-06 Kevin R. Stone Suture anchor assembly
US5500000A (en) 1993-07-01 1996-03-19 United States Surgical Corporation Soft tissue repair system and method
BR9302774A (en) 1993-07-06 1995-02-14 Antoine Jean Henri Robert Adjustable peri-urethral expander
US5382885A (en) * 1993-08-09 1995-01-17 The University Of British Columbia Motion scaling tele-operating system with force feedback suitable for microsurgery
CA2124651C (en) 1993-08-20 2004-09-28 David T. Green Apparatus and method for applying and adjusting an anchoring device
US5591206A (en) * 1993-09-30 1997-01-07 Moufarr+E,Gra E+Ee Ge; Richard Method and device for closing wounds
WO1995011631A1 (en) 1993-10-28 1995-05-04 Javin Pierce A suture anchor
US5876325A (en) * 1993-11-02 1999-03-02 Olympus Optical Co., Ltd. Surgical manipulation system
US5402793A (en) * 1993-11-19 1995-04-04 Advanced Technology Laboratories, Inc. Ultrasonic transesophageal probe for the imaging and diagnosis of multiple scan planes
US5527342A (en) 1993-12-14 1996-06-18 Pietrzak; William S. Method and apparatus for securing soft tissues, tendons and ligaments to bone
US5518504A (en) 1993-12-28 1996-05-21 American Medical Systems, Inc. Implantable sphincter system utilizing lifting means
AU1011595A (en) * 1994-01-13 1995-07-20 Ethicon Inc. Spiral surgical tack
US5480409A (en) * 1994-05-10 1996-01-02 Riza; Erol D. Laparoscopic surgical instrument
US5885288A (en) * 1994-05-24 1999-03-23 Endius Incorporated Surgical instrument
FR2720266B1 (en) 1994-05-27 1996-12-20 Cogent Sarl Prosthetic fabric.
JPH0829701A (en) * 1994-07-18 1996-02-02 Olympus Optical Co Ltd Stereoscopic viewing endoscope system
US5899909A (en) 1994-08-30 1999-05-04 Medscand Medical Ab Surgical instrument for treating female urinary incontinence
SE506164C2 (en) 1995-10-09 1997-11-17 Medscand Medical Ab Instruments for the treatment of urinary incontinence in women
US5742330A (en) * 1994-11-03 1998-04-21 Synthonics Incorporated Methods and apparatus for the creation and transmission of 3-dimensional images
JP3640087B2 (en) * 1994-11-29 2005-04-20 豊田工機株式会社 Machine Tools
JP3539645B2 (en) * 1995-02-16 2004-07-07 株式会社日立製作所 Remote surgery support device
US5643320A (en) 1995-03-13 1997-07-01 Depuy Inc. Soft tissue anchor and method
US5571139A (en) 1995-05-19 1996-11-05 Jenkins, Jr.; Joseph R. Bidirectional suture anchor
US5864359A (en) * 1995-05-30 1999-01-26 Smith & Nephew, Inc. Stereoscopic autofocusing based on comparing the left and right eye images
US6451024B1 (en) 1995-06-14 2002-09-17 Dexterity Surgical, Inc. Surgical method for treating urinary incontinence, and apparatus for use in same
US5591163A (en) * 1995-06-14 1997-01-07 Incont, Inc. Apparatus and method for laparoscopic urethropexy
US6042583A (en) 1995-06-14 2000-03-28 Medworks Corporation Bone anchor-insertion tool and surgical method employing same
US5997554A (en) 1995-06-14 1999-12-07 Medworks Corporation Surgical template and surgical method employing same
US5697931A (en) 1995-06-14 1997-12-16 Incont, Inc. Apparatus and method for laparoscopic urethopexy
US5669935A (en) 1995-07-28 1997-09-23 Ethicon, Inc. One-way suture retaining device for braided sutures
AUPN562295A0 (en) 1995-09-26 1995-10-19 Compton, Jeffrey Spencer Dr Easy load device for raney style scalp clips
WO1997016121A1 (en) 1995-10-31 1997-05-09 Karl Christopher Texler Surgical instruments
DE19544162C1 (en) 1995-11-17 1997-04-24 Ethicon Gmbh Implant for suspension of the bladder in urinary incontinence in women
EP0950385A3 (en) 1995-12-14 1999-10-27 Prograft Medical, Inc. Stent-graft deployment apparatus and method
US5725541A (en) * 1996-01-22 1998-03-10 The Anspach Effort, Inc. Soft tissue fastener device
US5741282A (en) 1996-01-22 1998-04-21 The Anspach Effort, Inc. Soft tissue fastener device
US5855583A (en) * 1996-02-20 1999-01-05 Computer Motion, Inc. Method and apparatus for performing minimally invasive cardiac procedures
US5785640A (en) 1996-05-23 1998-07-28 Kresch; Arnold J. Method for treating female incontinence
US5893856A (en) 1996-06-12 1999-04-13 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
US5782916A (en) 1996-08-13 1998-07-21 Galt Laboratories, Inc. Device for maintaining urinary continence
US6264676B1 (en) 1996-11-08 2001-07-24 Scimed Life Systems, Inc. Protective sheath for transvaginal anchor implantation devices
US6053935A (en) 1996-11-08 2000-04-25 Boston Scientific Corporation Transvaginal anchor implantation device
US5709708A (en) * 1997-01-31 1998-01-20 Thal; Raymond Captured-loop knotless suture anchor assembly
US5954057A (en) 1997-02-12 1999-09-21 Li Medical Technologies, Inc. Soft tissue suspension clip, clip assembly, emplacement tool and method
EP1017321B1 (en) 1997-02-13 2004-01-14 Boston Scientific Limited Percutaneous and hiatal devices for use in minimally invasive pelvic surgery
EP1006886B1 (en) 1997-02-13 2003-07-09 Boston Scientific Limited Dilator for minimally invasive pelvic surgery
AU6329598A (en) 1997-02-13 1998-09-08 Boston Scientific Ireland Limited, Barbados Head Office Stabilization sling for use in minimally invasive pelvic surgery
DE69839051T2 (en) 1997-03-07 2009-01-15 Disc-O-Tech Medical Technologies, Ltd. PERCUT BONE SYSTEMS AND SPINAL STABILIZATION, MOUNTING AND REPAIR
US6039686A (en) 1997-03-18 2000-03-21 Kovac; S. Robert System and a method for the long term cure of recurrent urinary female incontinence
US6599235B2 (en) 1997-03-18 2003-07-29 American Medical Systems Inc. Transvaginal bone anchor implantation device
US5782866A (en) 1997-03-25 1998-07-21 Ethicon, Inc. System for anchoring tissue to bone
US5934283A (en) 1997-04-15 1999-08-10 Uroplasty, Inc. Pubovaginal sling device
US5922026A (en) 1997-05-01 1999-07-13 Origin Medsystems, Inc. Surgical method and prosthetic strip therefor
IL133244A0 (en) 1997-06-02 2001-04-30 Martello Jeannette Soft tissue securing anchor
US6419624B1 (en) 1999-10-11 2002-07-16 Uromedica, Inc. Apparatus and method for inserting an adjustable implantable genitourinary device
US5988171A (en) 1997-06-26 1999-11-23 Influence Medical Technologies, Ltd. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US5944732A (en) 1997-08-27 1999-08-31 Medical Components, Inc. Subcutaneous tunnelling device and methods of forming a subcutaneous tunnel
US5980558A (en) 1997-09-30 1999-11-09 Biomet Inc. Suture anchor system
JP4070954B2 (en) 1997-10-01 2008-04-02 ボストン サイエンティフィック リミテッド Pelvic floor remodeling
US6027523A (en) * 1997-10-06 2000-02-22 Arthrex, Inc. Suture anchor with attached disk
US6099552A (en) 1997-11-12 2000-08-08 Boston Scientific Corporation Gastrointestinal copression clips
US6191809B1 (en) * 1998-01-15 2001-02-20 Vista Medical Technologies, Inc. Method and apparatus for aligning stereo images
US6096041A (en) 1998-01-27 2000-08-01 Scimed Life Systems, Inc. Bone anchors for bone anchor implantation device
US6221005B1 (en) 1998-02-17 2001-04-24 Norman I. Bruckner Pubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence with urethal hypemobility
US6068591A (en) 1998-02-17 2000-05-30 Bruckner; Norman I. Pubo-urethral support harness apparatus for percutaneous treatment of female stress urinary incontinence
US5984927A (en) 1998-03-03 1999-11-16 Ethicon, Inc. Device for sutureless attachment of soft tissue to bone
ES2149091B1 (en) 1998-03-10 2001-05-16 Gil Vernet Vila Jose Maria DEVICE FOR FIXING AND ADJUSTABLE SUPPORT AT HEIGHT OF INTERNAL ANATOMICAL ORGANS.
US6099551A (en) 1998-03-12 2000-08-08 Shelhigh, Inc. Pericardial strip and stapler assembly for dividing and sealing visceral tissues and method of use thereof
US6106545A (en) 1998-04-16 2000-08-22 Axya Medical, Inc. Suture tensioning and fixation device
IT1299162B1 (en) 1998-04-17 2000-02-29 Mauro Cervigni PROSTHETIC ASSEMBLY TO BE USED IN SURGICAL THERAPY OF UROGENITAL PROLAPSE
FR2777442B1 (en) 1998-04-21 2000-07-28 Tornier Sa REVERSIBLE EXPANSION SUTURE ANCHOR
US6382214B1 (en) * 1998-04-24 2002-05-07 American Medical Systems, Inc. Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
AU733868B2 (en) 1998-05-12 2001-05-31 Boston Scientific Limited Manual bone anchor placement devices
AU737877B2 (en) 1998-05-21 2001-09-06 Christopher J. Walshe A tissue anchor system
US6074341A (en) 1998-06-09 2000-06-13 Timm Medical Technologies, Inc. Vessel occlusive apparatus and method
US6010447A (en) * 1998-07-31 2000-01-04 Kardjian; Paul M. Bladder sling
US6042536A (en) 1998-08-13 2000-03-28 Contimed, Inc. Bladder sling
US6648903B1 (en) 1998-09-08 2003-11-18 Pierson, Iii Raymond H. Medical tensioning system
US6030393A (en) * 1998-09-15 2000-02-29 Corlew; Earvin L. Needle and procedure for relieving urinary incontinence
US6050937A (en) 1998-09-21 2000-04-18 Benderev; Theodore V. Surgical tension/pressure monitor
US6302840B1 (en) 1998-09-21 2001-10-16 Theodore V. Benderev Surgical monitor
ES2252981T3 (en) 1998-10-01 2006-05-16 Burger, Nicolaas Daniel Lombard DISTENSIBLE SUSPENSION DEVICE FOR URINARY INCONTINENCE.
US5925047A (en) 1998-10-19 1999-07-20 Third Millennium Engineering, Llc Coupled rod, anterior vertebral body screw, and staple assembly
FR2785521B1 (en) 1998-11-10 2001-01-05 Sofradim Production SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES
US20050004576A1 (en) * 1998-11-23 2005-01-06 Benderev Theodore V. System for securing sutures, grafts and soft tissue to bone and periosteum
US7410460B2 (en) 1998-11-23 2008-08-12 Benderev Theodore V System for securing sutures, grafts and soft tissue to bone and periosteum
US6200330B1 (en) 1998-11-23 2001-03-13 Theodore V. Benderev Systems for securing sutures, grafts and soft tissue to bone and periosteum
US7387634B2 (en) 1998-11-23 2008-06-17 Benderev Theodore V System for securing sutures, grafts and soft tissue to bone and periosteum
FR2787990B1 (en) 1998-12-30 2001-04-27 Medical Res & Man Llc PROSTHESIS FOR CORRECTING URINARY INCONTINENCE IN WOMEN
EP1187557A2 (en) 1999-01-08 2002-03-20 American Medical Systems International, Inc Surgical tack
US6099538A (en) 1999-02-02 2000-08-08 T.A.G. Medical Products Set of surgical tools and surgical method for connecting soft bone parts to one another or to connective tissue
US6287316B1 (en) 1999-03-26 2001-09-11 Ethicon, Inc. Knitted surgical mesh
US6981983B1 (en) * 1999-03-31 2006-01-03 Rosenblatt Peter L System and methods for soft tissue reconstruction
US20050283189A1 (en) 1999-03-31 2005-12-22 Rosenblatt Peter L Systems and methods for soft tissue reconstruction
FR2792824B1 (en) 1999-04-27 2001-06-22 Sofradim Production DEVICE FOR TREATING PROLAPSUS BY VAGINAL SUSPENSION
ATE427074T1 (en) 1999-04-30 2009-04-15 Uromedica Inc DEVICE HAVING AN ADJUSTABLE SLING FOR TREATING STRESS-RELATED URINARY INCONTINENCE
IL130307A0 (en) 1999-06-04 2000-06-01 Influence Med Tech Ltd Bone suturing device
ATE334639T1 (en) 1999-06-08 2006-08-15 Ethicon Inc SURGICAL KNITTED FABRIC
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
US6273852B1 (en) 1999-06-09 2001-08-14 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
EP1581162B1 (en) 1999-06-09 2011-04-20 Ethicon, Inc. Apparatus for adjusting flexible areal polymer implants
US7121997B2 (en) 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US6475139B1 (en) 1999-06-09 2002-11-05 Ethicon, Inc. Visually-directed surgical instrument and method for treating female urinary incontinence
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
IT1313574B1 (en) 1999-07-27 2002-09-09 Angiologica B M S R L CORRECTIVE NETWORK FOR BODY FABRICS.
US6168611B1 (en) * 1999-09-08 2001-01-02 Syed Rizvi Suturing needle assemblies and methods of use thereof
AUPQ362199A0 (en) 1999-10-22 1999-11-18 Kaladelfos, George Intra-vaginal sling placement device
US6599318B1 (en) 1999-11-30 2003-07-29 Shlomo Gabbay Implantable support apparatus and method of using same
US6306079B1 (en) 1999-12-07 2001-10-23 Arnaldo F. Trabucco Mesh pubovaginal sling
DE19961218A1 (en) 1999-12-15 2001-07-05 Ethicon Gmbh Surgical needle for implanting a band
FR2802798B1 (en) 1999-12-22 2002-02-01 Promedon S A PAD STRAP FOR THE TREATMENT OF URINARY INCONTINENCE
US6406423B1 (en) 2000-01-21 2002-06-18 Sofradim Production Method for surgical treatment of urinary incontinence and device for carrying out said method
GB2359256B (en) 2000-01-21 2004-03-03 Sofradim Production Percutaneous device for treating urinary stress incontinence in women using a sub-urethral tape
DE10004832A1 (en) 2000-01-31 2001-08-16 Ethicon Gmbh Flat implant with X-ray visible elements
US6414179B1 (en) 2000-02-18 2002-07-02 Bristol-Myers Squibb Company Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors
CA2404469C (en) 2000-02-21 2009-06-30 Larry R. Russell Antiextrusion device
US7131943B2 (en) 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
US6837846B2 (en) * 2000-04-03 2005-01-04 Neo Guide Systems, Inc. Endoscope having a guide tube
US20020007222A1 (en) * 2000-04-11 2002-01-17 Ashvin Desai Method and apparatus for supporting a body organ
US6908473B2 (en) 2000-04-14 2005-06-21 Jeffry B. Skiba Tissue anchoring devices, biological vessel suspending devices and systems and methods utilizing same
US6482214B1 (en) 2000-04-27 2002-11-19 Medtronic, Inc. Intravascular seal with mesh reinforcement and method for using same
US6596001B2 (en) 2000-05-01 2003-07-22 Ethicon, Inc. Aiming device for surgical instrument and method for use for treating female urinary incontinence
US6638211B2 (en) 2000-07-05 2003-10-28 Mentor Corporation Method for treating urinary incontinence in women and implantable device intended to correct urinary incontinence
US6494906B1 (en) 2000-07-25 2002-12-17 Advanced Cardiovascular Systems, Inc. Stent fold clip
US7025063B2 (en) 2000-09-07 2006-04-11 Ams Research Corporation Coated sling material
US6592515B2 (en) 2000-09-07 2003-07-15 Ams Research Corporation Implantable article and method
CA2777791A1 (en) 2000-09-18 2002-03-21 Organogenesis Inc. Methods for treating a patient using a bioengineered flat sheet graft prostheses
DE60140886D1 (en) 2000-09-26 2010-02-04 Ethicon Inc SURGICAL APPARATUS FOR DISPENSING A SLING IN THE TREATMENT OF HARNESS INCONTINENCE IN WOMEN
US6503190B1 (en) 2000-09-29 2003-01-07 Ethicon Endo-Surgery, Inc. Vaginal pessary
DE20016866U1 (en) 2000-09-30 2000-12-14 Wendt Adalbert Tool to unlock a lock cylinder
FR2814939B1 (en) * 2000-10-05 2002-12-20 Sofradim Production SUB-URETRAL SUPPORT KIT FOR THE TREATMENT OF URINARY INCONTINENCE OF FEMALE EXERCISE
US6702827B1 (en) 2000-10-06 2004-03-09 American Medical Systems Sling adjustment and tensioning accessory
US7299803B2 (en) 2000-10-09 2007-11-27 Ams Research Corporation Pelvic surgery drape
GB0025068D0 (en) 2000-10-12 2000-11-29 Browning Healthcare Ltd Apparatus and method for treating female urinary incontinence
US6605097B1 (en) 2000-10-18 2003-08-12 Jorn Lehe Apparatus and method for treating female urinary incontinence
US6638209B2 (en) 2000-10-20 2003-10-28 Ethicon Gmbh System with a surgical needle and a handle
KR20030081323A (en) 2000-10-23 2003-10-17 에디컨인코포레이티드 Apparatus and method for measurement and assessment of sling-tension for treatment of female urinary incontinence
DE10065919A1 (en) 2000-11-07 2002-05-29 Bosch Gmbh Robert Coded modulation method
DE10056169C2 (en) 2000-11-13 2003-07-03 Ethicon Gmbh Implant for holding the female bladder
WO2002039914A1 (en) 2000-11-15 2002-05-23 Scimed Life Systems, Inc. Device and method for treating female urinary incontinence
WO2002039890A2 (en) 2000-11-20 2002-05-23 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US20020128670A1 (en) 2000-11-22 2002-09-12 Ulf Ulmsten Surgical instrument and method for treating female urinary incontinence
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US6582443B2 (en) 2000-12-27 2003-06-24 Ams Research Corporation Apparatus and methods for enhancing the functional longevity and for facilitating the implantation of medical devices
US20020161382A1 (en) 2001-03-29 2002-10-31 Neisz Johann J. Implant inserted without bone anchors
US6641525B2 (en) 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
US7229453B2 (en) 2001-01-23 2007-06-12 Ams Research Corporation Pelvic floor implant system and method of assembly
US7070556B2 (en) * 2002-03-07 2006-07-04 Ams Research Corporation Transobturator surgical articles and methods
US6652450B2 (en) 2001-01-23 2003-11-25 American Medical Systems, Inc. Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
US20020147382A1 (en) 2001-01-23 2002-10-10 Neisz Johann J. Surgical articles and methods
AT409216B (en) 2001-01-23 2002-06-25 Grabner Gerald Dr Method for monitoring the wearing of corrective devices
US6602260B2 (en) 2001-02-02 2003-08-05 Ams Research Corporation Powered bone screw device
CH696585A5 (en) 2001-02-25 2007-08-15 Alvaro De Oliveira Prado Method and apparatus for treating carbonaceous Good.
US9149261B2 (en) 2001-03-09 2015-10-06 Boston Scientific Scimed, Inc. Systems, methods and devices relating to delivery of medical implants
US7364541B2 (en) 2001-03-09 2008-04-29 Boston Scientific Scimed, Inc. Systems, methods and devices relating to delivery of medical implants
US20050131393A1 (en) 2001-03-09 2005-06-16 Scimed Life Systems, Inc. Systems, methods and devices relating to delivery of medical implants
CA2440153C (en) 2001-03-09 2011-09-20 Scimed Life Systems, Inc. System for implanting an implant and method thereof
EP1913896B1 (en) * 2001-03-09 2012-12-26 Boston Scientific Limited Method for making a medical sling
AUPR406501A0 (en) 2001-03-28 2001-04-26 Kaladelfos, George Treatment of vault prolapse
FR2824257B1 (en) 2001-05-07 2004-01-30 Bernard Guerquin INTRA-VAGINAL DEVICE FOR PREVENTING FEMALE URINARY INCONTINENCE DURING EXERCISE
DE10123934A1 (en) 2001-05-17 2002-12-05 Ethicon Gmbh Flat implant
US20020182261A1 (en) * 2001-05-31 2002-12-05 Jianwu Dai EB matrix production from fetal tissues and its use for tissue repair
US20030004581A1 (en) * 2001-06-27 2003-01-02 Rousseau Robert A. Implantable prosthetic mesh system
ITMI20011376A1 (en) 2001-06-29 2002-12-29 Siemens Inf & Comm Networks PROCEDURE FOR THE CONTROL OF PACKAGE SWITCHING TRAFFIC IN NUMERICAL MOBILE COMMUNICATION SYSTEMS
US7407480B2 (en) 2001-07-27 2008-08-05 Ams Research Corporation Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele
US7037255B2 (en) 2001-07-27 2006-05-02 Ams Research Corporation Surgical instruments for addressing pelvic disorders
US6755781B2 (en) 2001-07-27 2004-06-29 Scimed Life Systems, Inc. Medical slings
JP3646163B2 (en) * 2001-07-31 2005-05-11 国立大学法人 東京大学 Active forceps
ATE332674T1 (en) 2001-08-03 2006-08-15 Aesculap Ag & Co Kg INCONTINENCE BAND FOR THE TREATMENT OF URINARY INCONTINENCE
DE10141234A1 (en) 2001-08-23 2003-03-13 Ethicon Gmbh System with a surgical needle and a handle
US6676684B1 (en) * 2001-09-04 2004-01-13 Intuitive Surgical, Inc. Roll-pitch-roll-yaw surgical tool
US20040073235A1 (en) 2001-10-01 2004-04-15 Lund Robert E. Surgical article
US6830052B2 (en) 2001-10-03 2004-12-14 Solarant Medical, Inc. Urethral support for incontinence
US6648921B2 (en) 2001-10-03 2003-11-18 Ams Research Corporation Implantable article
US7087065B2 (en) 2001-10-04 2006-08-08 Ethicon, Inc. Mesh for pelvic floor repair
US6673010B2 (en) * 2001-10-22 2004-01-06 T. A. G. Medical Products Ltd. Biological vessel suspending assembly and systems and methods utilizing same
DE10153334B4 (en) 2001-10-29 2004-04-29 Ethicon Gmbh Flat implant
DE10155842A1 (en) 2001-11-14 2003-05-28 Ethicon Gmbh Flat implant
IL146534A (en) 2001-11-15 2007-06-17 Gynotech Ltd Adjustable vaginal pessary
DE10159181A1 (en) 2001-12-03 2003-06-26 Ethicon Gmbh Surgical auxiliary instrument
US6974462B2 (en) 2001-12-19 2005-12-13 Boston Scientific Scimed, Inc. Surgical anchor implantation device
PT1487377E (en) 2002-03-01 2012-11-23 Ethicon Inc Apparatus for treating pelvic organ prolapses in female patients
US6911003B2 (en) 2002-03-07 2005-06-28 Ams Research Corporation Transobturator surgical articles and methods
US7357773B2 (en) 2002-03-07 2008-04-15 Ams Research Corporation Handle and surgical article
AU2003213688B2 (en) 2002-03-07 2008-10-02 Ams Research Corporation Transobturator surgical articles and methods
US8968178B2 (en) 2002-03-07 2015-03-03 Ams Research Corporation Transobturator surgical articles and methods
FR2836820B1 (en) 2002-03-08 2004-12-17 Vincent Goria SURGICAL DEVICE AND STRIP FOR THE TREATMENT OF URINARY EFFORT INCONTINENCE IN WOMEN
ITRE20020021A1 (en) 2002-03-08 2003-09-08 Ufi Universal Filter Int Spa FUEL FILTER WITH HEATING DEVICE
DE10211360A1 (en) 2002-03-14 2003-10-09 Ethicon Gmbh Implantate band and surgical needle system to support female urethra has distal end region of needle narrower than implantate band
CA2481275C (en) 2002-04-11 2011-10-25 Gyne Ideas Limited Apparatus and method for treating female urinary incontinence
EP1501444B1 (en) 2002-04-30 2014-05-07 Cook Medical Technologies LLC Sling for supporting tissue
KR20050010765A (en) 2002-05-07 2005-01-28 에이엠에스 리써치 코오포레이션 Urethral prosthesis with tensioning member
NZ518967A (en) 2002-05-15 2004-11-26 Livestock Improvement Corp Ltd Straws (inter alia) for insemination of animals
ATE322227T1 (en) 2002-05-22 2006-04-15 Sofradim Production SUBURETHRAL SUPPORT ARRANGEMENT FOR THE TREATMENT OF FEMALE STRESS-RELATED URINARY INCONTINENCE
AU2003245470A1 (en) 2002-06-12 2003-12-31 Boston Scientific Limited Medical slings
AU2003299526A1 (en) 2002-06-14 2004-06-07 North Shore - Long Island Jewish Research Institute Novel human elastases and stress urinary incontinence
US6881184B2 (en) 2002-07-16 2005-04-19 Stephen M. Zappala Absorbable pubovaginal sling system and method
EP1525283B1 (en) 2002-07-26 2009-09-16 Arkema France Use of a block copolymer comprising at least one hydrophilic block
ITFI20020145A1 (en) 2002-08-01 2004-02-02 Giulio Nicita DEVICE FOR THE SURGICAL TREATMENT OF FEMALE PROLAXIS.
US7371245B2 (en) 2002-08-02 2008-05-13 C R Bard, Inc Transobturator introducer system for sling suspension system
WO2004016196A2 (en) 2002-08-14 2004-02-26 Boston Scientific Limited Systems, methods and devices relating to delivery of medical implants
EA007116B1 (en) 2002-08-23 2006-06-30 Квинно Сентр Пти Лтд. Anchoring device and its implementation
US7611454B2 (en) 2002-08-29 2009-11-03 Universite De Liege Surgical procedure for the treatment of female urinary incontinence: tension-free inside-out transobturator urethral suspension
FR2843876B1 (en) 2002-08-30 2004-11-26 Bernard Bouffier SURGICAL PROSTHESIS DEVICE FOR THE IMPLANTATION OF A SUPPORT OF A MAMMALIAN BODY
KR101133460B1 (en) 2002-11-15 2012-04-09 에디컨인코포레이티드 A kit suitable for use in repairing of vagina damaged by pelvic organ prolapse
CN100389730C (en) * 2002-12-06 2008-05-28 直观外科手术公司 Flexible wrist for surgical tool
FR2852813B1 (en) * 2003-03-28 2005-06-24 Analytic Biosurgical Solutions INTRODUCER AND PERFORATOR GUIDE FOR THE IMPLEMENTATION OF A BANDLET IN THE HUMAN BODY
BRPI0408903A (en) 2003-03-28 2006-03-28 Analytic Biosurgical Solutions implant for treatment of the rectocele and / or vaginal dome prolapse, device for inserting an implant and process for treating the rectocele in a woman
US7494495B2 (en) * 2003-03-28 2009-02-24 Coloplast A/S Method and implant for curing cystocele
US20070078295A1 (en) 2003-04-03 2007-04-05 Susanne Landgrebe Surgical implant system for treating female urinary incontinence
US7273448B2 (en) 2003-04-24 2007-09-25 Ams Research Corporation Male urethral prosthesis
EP2471468B1 (en) 2003-04-25 2016-02-24 Boston Scientific Limited Systems for surgical sling delivery and placement
ITRM20030210A1 (en) * 2003-04-30 2004-11-01 Mauro Cervigni PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY
US6981944B2 (en) * 2003-07-07 2006-01-03 Ethicon, Inc. Implantable surgical mesh having a lubricious coating
CA2532882A1 (en) 2003-07-11 2005-01-20 Endogun Medical Systems Ltd. Surgical fasteners and devices for surgical fastening
EP1684661A1 (en) * 2003-08-14 2006-08-02 Boston Scientific Limited Medical slings
US7303525B2 (en) 2003-08-22 2007-12-04 Ams Research Corporation Surgical article and methods for treating female urinary incontinence
US7347812B2 (en) 2003-09-22 2008-03-25 Ams Research Corporation Prolapse repair
US7393319B2 (en) 2003-10-14 2008-07-01 Caldera Medical, Inc. Implantable sling having bladder support
US20060028828A1 (en) * 2003-10-31 2006-02-09 Phillips Todd L Light fixture candle assembly
US7261723B2 (en) 2003-11-12 2007-08-28 Ethicon, Inc. Surgical instrument and method for the treatment of urinary incontinence
ES2435513T3 (en) 2003-11-17 2013-12-20 Lyra Medical Ltd. Pelvic implant with anchor frame
EP1696803B1 (en) 2003-11-17 2016-09-28 Boston Scientific Limited Systems relating to associating a medical implant with a delivery device
AU2005215814B2 (en) 2004-02-19 2010-06-24 Ams Research Corporation Prolapse repair
US20050199249A1 (en) 2004-03-15 2005-09-15 Karram Mickey M. Apparatus and method for incision-free vaginal prolapse repair
JP2007529261A (en) 2004-03-18 2007-10-25 コンティピ リミテッド Female pelvic organ prolapse treatment device
US20050234291A1 (en) 2004-03-30 2005-10-20 Peter Gingras Medical device
US7500945B2 (en) 2004-04-30 2009-03-10 Ams Research Corporation Method and apparatus for treating pelvic organ prolapse
US7351197B2 (en) 2004-05-07 2008-04-01 Ams Research Corporation Method and apparatus for cystocele repair
EP1744679A2 (en) 2004-05-03 2007-01-24 AMS Research Corporation Surgical implants and related methods
US8062206B2 (en) * 2004-05-07 2011-11-22 Ams Research Corporation Method and apparatus for treatment of vaginal anterior repairs
GB0411360D0 (en) 2004-05-21 2004-06-23 Mpathy Medical Devices Ltd Implant
FR2871364B1 (en) 2004-06-10 2007-09-14 Cie De Rech En Composants Impl PROTHETIC IMPLANT OF SUPPORT UNDER URETRAL AND SURGICAL INSTRUMENT FOR ITS IMPLANTATION
US20050278037A1 (en) 2004-06-11 2005-12-15 Analytic Biosurgical Solutions-Abiss Implant for the treatment of cystocele and rectocele
AU2005254105B2 (en) 2004-06-14 2012-01-12 Boston Scientific Limited Systems, methods and devices relating to implantable supportive slings
US20050288689A1 (en) 2004-06-25 2005-12-29 Kammerer Gene W Applicator and method for deploying a surgical fastener
US20050288708A1 (en) 2004-06-25 2005-12-29 Kammerer Gene W Soft tissue fastener having integral biasing section
WO2006015031A2 (en) 2004-07-28 2006-02-09 Ethicon, Inc. Minimally invasive medical implant and insertion device and method for using the same
US7085870B2 (en) 2004-09-07 2006-08-01 Altera Corporation Integrated circuit with shared hotsocket architecture
US7527588B2 (en) 2004-09-15 2009-05-05 Ethicon, Inc. System and method for surgical implant placement
WO2006041861A2 (en) 2004-10-05 2006-04-20 Ams Research Corporation Device and method for supporting vaginal cuff
US8500624B2 (en) 2004-10-25 2013-08-06 Boston Scientific Scimed, Inc. Systems and methods for sling delivery and placement
US7794385B2 (en) 2004-12-20 2010-09-14 Ams Research Corporation System and method for treatment of anal incontinence and pelvic organ prolapse
US7914437B2 (en) 2005-02-04 2011-03-29 Ams Research Corporation Transobturator methods for installing sling to treat incontinence, and related devices
US7722528B2 (en) 2005-02-04 2010-05-25 Ams Research Corporation Surgical implants and related methods and systems
US20060217589A1 (en) 2005-03-22 2006-09-28 Wan Shaw P Pubovaginal sling implanter and procedure for the usage
BRPI0609970A2 (en) * 2005-04-05 2011-10-11 Ams Res Corp pelvic implant, surgical instrument and combination
EP2881082B8 (en) 2005-04-06 2021-12-29 Boston Scientific Medical Device Limited Systems and devices for treating pelvic floor disorders
US7393320B2 (en) 2005-04-29 2008-07-01 Ams Research Corporation Pelvic floor health articles and procedures
US7431690B2 (en) 2005-04-30 2008-10-07 Coloplast A/S Implantable sling for the treatment of male incontinence and method of using the same
US20060252980A1 (en) 2005-05-04 2006-11-09 Arnal Kevin R Methods and Apparatus for Securing and Tensioning a Urethral Sling to Pubic Bone
EP1909687A1 (en) * 2005-07-13 2008-04-16 Boston Scientific Scimed, Inc. Snap fit sling anchor system and related methods
US9248010B2 (en) 2005-07-15 2016-02-02 Boston Scientific Scimed, Inc. Tension-adjustable surgical sling assembly
EP3533416A1 (en) 2005-07-25 2019-09-04 Boston Scientific Limited Pelvic floor repair system
WO2007016083A1 (en) 2005-07-26 2007-02-08 Ams Research Corporation Methods and systems for treatment of prolapse
US20080207989A1 (en) 2005-08-29 2008-08-28 Ams Research Corporation System For Positioning Support Mesh in a Patient
US20090221867A1 (en) 2005-11-11 2009-09-03 Ams Research Corporation Integral Sling Connection System and Method
EP1948073B1 (en) 2005-11-14 2014-03-19 C.R.Bard, Inc. Sling anchor system
US7637860B2 (en) 2005-11-16 2009-12-29 Boston Scientific Scimed, Inc. Devices for minimally invasive pelvic surgery
US7513865B2 (en) 2005-12-20 2009-04-07 Boston Scientific Scimed, Inc. Flattened tubular mesh sling and related methods
AU2006332514B2 (en) 2005-12-28 2013-01-17 C.R. Bard, Inc. Apparatus and method for introducing implants
US8585577B2 (en) * 2006-01-10 2013-11-19 Ams Research Corporation Multi-leveled transgluteal tension-free levatorplasty for treatment of Rectocele
EP1978890A1 (en) 2006-01-10 2008-10-15 Hallum, Alton, V Levator for repair of perineal prolapse
WO2007081954A1 (en) * 2006-01-10 2007-07-19 Beyer Roger D Apparatus for posterior pelvic floor repair
US9144483B2 (en) 2006-01-13 2015-09-29 Boston Scientific Scimed, Inc. Placing fixation devices
AU2007217930B2 (en) 2006-02-16 2012-10-18 Boston Scientific Scimed, Inc. Surgical articles and methods for treating pelvic conditions
WO2007137226A2 (en) 2006-05-19 2007-11-29 Ams Research Corporation Method and articles for treatment of stress urinary incontinence
AU2007257870B2 (en) 2006-06-08 2013-08-15 Boston Scientific Scimed, Inc. Method and apparatus for levator distension repair
JP4971440B2 (en) 2006-06-16 2012-07-11 エーエムエス リサーチ コーポレイション Surgical implants, tools, and methods for treating pelvic disease
AU2007261254B2 (en) 2006-06-22 2013-12-12 Boston Scientific Scimed, Inc. Adjustable tension incontinence sling assemblies
US20090259092A1 (en) 2006-06-22 2009-10-15 Ogdahl Jason W Adjustable Sling and Method of Treating Pelvic Conditions
US8388514B2 (en) 2006-10-26 2013-03-05 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
WO2008124056A1 (en) 2007-04-04 2008-10-16 Ams Research Corporation Kit for levator avulsion repair
US7645227B2 (en) * 2007-05-14 2010-01-12 Ethicon, Inc. Implants and methods for pelvic floor repair
AU2008271061B2 (en) 2007-06-29 2013-11-14 Boston Scientific Scimed, Inc. Surgical articles and methods for treating pelvic conditions
CA2693198C (en) 2007-07-27 2014-10-14 Ams Research Corporation Pelvic floor treatments and related tools and implants

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099258A1 (en) * 2001-01-23 2002-07-25 Staskin David R. Sling delivery system and method of use

Also Published As

Publication number Publication date
EP1912590A1 (en) 2008-04-23
AU2006275977B2 (en) 2012-08-30
BRPI0613896A2 (en) 2016-11-16
US8535217B2 (en) 2013-09-17
US20090192347A1 (en) 2009-07-30
AU2006275977A1 (en) 2007-02-08
WO2007016083A1 (en) 2007-02-08
US9283064B2 (en) 2016-03-15
US9060839B2 (en) 2015-06-23
US20140179990A1 (en) 2014-06-26
US20150282920A1 (en) 2015-10-08
CA2615130A1 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
US9283064B2 (en) Methods and systems for treatment of prolapse
US9937029B2 (en) Surgical articles and methods for treating pelvic conditions
US8801595B2 (en) Articles, devices, and methods for pelvic surgery
AU2006202854B2 (en) Method of treating anal incontinence
US9492191B2 (en) Tools and methods for treatment of pelvic conditions
AU2009251827B2 (en) Minimally invasive levator avulsion repair
WO2010028242A1 (en) System for combined anterior and posterior prolapse repair
EP2608736B1 (en) Centering aid for implantable sling
US20160317273A1 (en) Adjustable implants and methods of implanting the same
AU2014237186B2 (en) Systems, tools, and methods for connecting to tissue
AU2012254892B2 (en) Methods and Systems for Treatment of Prolapse
AU2015201961B2 (en) Method of treating anal incontinence

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE